Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 568 articles:
HTML format
Text format



Single Articles


    January 2017
  1. CARVALHO AC, Leal F, Sasse AD
    Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer.
    PLoS One. 2017;12:e0175409.
    PubMed     Text format     Abstract available


  2. GERTH HU, Pohlen M, Tholking G, Pavenstadt H, et al
    Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study.
    PLoS One. 2017;12:e0175529.
    PubMed     Text format     Abstract available


  3. YAO L, Chen W, Song K, Han C, et al
    15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.
    PLoS One. 2017;12:e0176106.
    PubMed     Text format     Abstract available


  4. LYTLE KA, Wong CP, Jump DB
    Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    PLoS One. 2017;12:e0173376.
    PubMed     Text format     Abstract available


  5. HE J, Yi B, Chen Y, Huang Q, et al
    The ET-1-mediated carbonylation and degradation of ANXA1 induce inflammatory phenotype and proliferation of pulmonary artery smooth muscle cells in HPS.
    PLoS One. 2017;12:e0175443.
    PubMed     Text format     Abstract available


  6. ALVA A, Cangalaya C, Quiliano M, Krebs C, et al
    Mathematical algorithm for the automatic recognition of intestinal parasites.
    PLoS One. 2017;12:e0175646.
    PubMed     Text format     Abstract available


  7. PEREZ P, Rodriguez-Peralvarez M, Guerrero L, Gonzalez V, et al
    Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact.
    PLoS One. 2017;12:e0175010.
    PubMed     Text format     Abstract available


  8. IBUSUKI R, Uto H, Oda K, Ohshige A, et al
    Human neutrophil peptide-1 promotes alcohol-induced hepatic fibrosis and hepatocyte apoptosis.
    PLoS One. 2017;12:e0174913.
    PubMed     Text format     Abstract available


  9. PEREYRA D, Offensperger F, Klinglmueller F, Haegele S, et al
    Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity.
    PLoS One. 2017;12:e0175359.
    PubMed     Text format     Abstract available


  10. KANG YM, Jung CH, Cho YK, Lee SE, et al
    Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.
    PLoS One. 2017;12:e0175762.
    PubMed     Text format     Abstract available


  11. YOON K, Jeong WK, Kim Y, Kim MY, et al
    2-dimensional shear wave elastography: Interobserver agreement and factors related to interobserver discrepancy.
    PLoS One. 2017;12:e0175747.
    PubMed     Text format     Abstract available


  12. ROTH JA, Widmer AF, Tschudin-Sutter S, Dangel M, et al
    The Model for End-stage Liver Disease (MELD) as a predictor of short-term mortality in Staphylococcus aureus bloodstream infection: A single-centre observational study.
    PLoS One. 2017;12:e0175669.
    PubMed     Text format     Abstract available


  13. WANKHADE UD, Zhong Y, Kang P, Alfaro M, et al
    Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations.
    PLoS One. 2017;12:e0175675.
    PubMed     Text format     Abstract available


  14. MCPHERSON S, Wilkinson N, Tiniakos D, Wilkinson J, et al
    A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0175717.
    PubMed     Text format     Abstract available


  15. YANG SC, Hsu CN, Liang CM, Tai WC, et al
    Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study.
    PLoS One. 2017;12:e0168918.
    PubMed     Text format     Abstract available


  16. MULDER P, van den Hoek AM, Kleemann R
    The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis.
    PLoS One. 2017;12:e0169740.
    PubMed     Text format     Abstract available


  17. WANG HL, Zhang H, Wu SL, Liao GC, et al
    Red blood cell count has an independent contribution to the prediction of ultrasonography-diagnosed fatty liver disease.
    PLoS One. 2017;12:e0172027.
    PubMed     Text format     Abstract available


  18. GRZELAK CA, Sigglekow ND, Tirnitz-Parker JE, Hamson EJ, et al
    Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease.
    PLoS One. 2017;12:e0171480.
    PubMed     Text format     Abstract available


  19. GIMENEZ-GARZO C, Garces JJ, Urios A, Mangas-Losada A, et al
    The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients.
    PLoS One. 2017;12:e0171211.
    PubMed     Text format     Abstract available


  20. TRAYKOVA D, Schneider B, Chojkier M, Buck M, et al
    Blood Microbiome Quantity and the Hyperdynamic Circulation in Decompensated Cirrhotic Patients.
    PLoS One. 2017;12:e0169310.
    PubMed     Text format     Abstract available


  21. HU W, Shao X, Guo D, Hao H, et al
    Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population.
    PLoS One. 2017;12:e0170758.
    PubMed     Text format     Abstract available


  22. CROOME KP, Lee DD, Harnois D, Taner CB, et al
    Effects of the Share 35 Rule on Waitlist and Liver Transplantation Outcomes for Patients with Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0170673.
    PubMed     Text format     Abstract available


  23. ZHAO J, Zhai F, Cheng J, He Q, et al
    Evaluating the Significance of Viscoelasticity in Diagnosing Early-Stage Liver Fibrosis with Transient Elastography.
    PLoS One. 2017;12:e0170073.
    PubMed     Text format     Abstract available


  24. XU X, Su L, Gao Y, Ding Y, et al
    The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.
    PLoS One. 2017;12:e0169952.
    PubMed     Text format     Abstract available


  25. WAKAMATSU T, Ogasawara S, Chiba T, Yokoyama M, et al
    Impact of Radiofrequency Ablation-Induced Glisson's Capsule-Associated Complications in Patients with Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0170153.
    PubMed     Text format     Abstract available


  26. RISHI P, Arora S, Kaur UJ, Chopra K, et al
    Better Management of Alcohol Liver Disease Using a 'Microstructured Synbox' System Comprising L. plantarum and EGCG.
    PLoS One. 2017;12:e0168459.
    PubMed     Text format     Abstract available


  27. YOUNS M, Abdel Halim Hegazy W
    The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways.
    PLoS One. 2017;12:e0169335.
    PubMed     Text format     Abstract available


  28. KARAJAMAKI AJ, Kettunen O, Lepojarvi S, Koivurova OP, et al
    Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.
    PLoS One. 2017;12:e0173855.
    PubMed     Text format     Abstract available


  29. CANNITO S, Morello E, Bocca C, Foglia B, et al
    Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0172575.
    PubMed     Text format     Abstract available


  30. JIN F, Wan C, Li W, Yao L, et al
    Formononetin protects against acetaminophen-induced hepatotoxicity through enhanced NRF2 activity.
    PLoS One. 2017;12:e0170900.
    PubMed     Text format     Abstract available


  31. SOTHMANN T, Gauer T, Werner R
    4D dose simulation in volumetric arc therapy: Accuracy and affecting parameters.
    PLoS One. 2017;12:e0172810.
    PubMed     Text format     Abstract available


  32. HOLLENBACH M, Thonig A, Pohl S, Ripoll C, et al
    Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis.
    PLoS One. 2017;12:e0171260.
    PubMed     Text format     Abstract available


  33. SHEU MJ, Hsieh MJ, Chou YE, Wang PH, et al
    Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma.
    PLoS One. 2017;12:e0172506.
    PubMed     Text format     Abstract available


  34. BORGATTI A, Winter AL, Stuebner K, Scott R, et al
    Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.
    PLoS One. 2017;12:e0172651.
    PubMed     Text format     Abstract available


  35. LI Q, Wang Y, Ma T, Lv Y, et al
    Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0171129.
    PubMed     Text format     Abstract available


  36. ZHANG BB, Yan C, Fang F, Du Y, et al
    Increased hepatic Th2 and Treg subsets are associated with biliary fibrosis in different strains of mice caused by Clonorchis sinensis.
    PLoS One. 2017;12:e0171005.
    PubMed     Text format     Abstract available


  37. WERNLY B, Lichtenauer M, Franz M, Kabisch B, et al
    Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
    PLoS One. 2017;12:e0170987.
    PubMed     Text format     Abstract available


  38. SALDANA RS, Schrem H, Barthold M, Kaltenborn A, et al
    Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients.
    PLoS One. 2017;12:e0170499.
    PubMed     Text format     Abstract available


  39. YOO JE, Kim YJ, Rhee H, Kim H, et al
    Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis.
    PLoS One. 2017;12:e0170465.
    PubMed     Text format     Abstract available


  40. LEE DH, Lee JH, Jung YJ, Gim J, et al
    Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area.
    PLoS One. 2017;12:e0170394.
    PubMed     Text format     Abstract available


  41. GAO W, Zhao J, Gao Z, Li H, et al
    Synergistic Interaction of Light Alcohol Administration in the Presence of Mild Iron Overload in a Mouse Model of Liver Injury: Involvement of Triosephosphate Isomerase Nitration and Inactivation.
    PLoS One. 2017;12:e0170350.
    PubMed     Text format     Abstract available


  42. LEE LH, Hwang JI, Cheng YC, Wu CY, et al
    Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0169655.
    PubMed     Text format     Abstract available


  43. LU M, Zessin AS, Glover W, Hsu DS, et al
    Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.
    PLoS One. 2017;12:e0169439.
    PubMed     Text format     Abstract available


  44. LE MH, Devaki P, Ha NB, Jun DW, et al
    Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.
    PLoS One. 2017;12:e0173499.
    PubMed     Text format     Abstract available


  45. MO HY, Liao YY, You XM, Cucchetti A, et al
    Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.
    PLoS One. 2017;12:e0174222.
    PubMed     Text format     Abstract available


  46. MA S, Yang J, Song C, Ge Z, et al
    Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma.
    PLoS One. 2017;12:e0173700.
    PubMed     Text format     Abstract available


  47. TROUVE P, Genin E, Ferec C
    In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis.
    PLoS One. 2017;12:e0173822.
    PubMed     Text format     Abstract available


  48. ABO-HADED HM, Elkablawy MA, Al-Johani Z, Al-Ahmadi O, et al
    Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity.
    PLoS One. 2017;12:e0174295.
    PubMed     Text format     Abstract available


  49. XIE Z, Wang J, Liu M, Chen D, et al
    CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo.
    PLoS One. 2017;12:e0173252.
    PubMed     Text format     Abstract available


  50. BECKER S, Kinny-Koster B, Bartels M, Scholz M, et al
    Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis.
    PLoS One. 2017;12:e0174424.
    PubMed     Text format     Abstract available


  51. SU YW, Liu PH, Hsu CY, Lee YH, et al
    Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.
    PLoS One. 2017;12:e0174333.
    PubMed     Text format     Abstract available


  52. HOLMILA R, Sklias A, Muller DC, Degli Esposti D, et al
    Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma.
    PLoS One. 2017;12:e0174265.
    PubMed     Text format     Abstract available


  53. LOWDON RF, Wang T
    Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer.
    PLoS One. 2017;12:e0174032.
    PubMed     Text format     Abstract available


  54. WIEGERING A, Riegel J, Wagner J, Kunzmann V, et al
    The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases.
    PLoS One. 2017;12:e0173933.
    PubMed     Text format     Abstract available


  55. GUTIERREZ-DE-JUAN V, Lopez de Davalillo S, Fernandez-Ramos D, Barbier-Torres L, et al
    A morphological method for ammonia detection in liver.
    PLoS One. 2017;12:e0173914.
    PubMed     Text format     Abstract available


  56. INZAUGARAT ME, De Matteo E, Baz P, Lucero D, et al
    New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans.
    PLoS One. 2017;12:e0172900.
    PubMed     Text format     Abstract available


  57. KATHER JN, Zollner FG, Schad LR, Melchers SM, et al
    Identification of a characteristic vascular belt zone in human colorectal cancer.
    PLoS One. 2017;12:e0171378.
    PubMed     Text format     Abstract available


  58. LEE J, Yoon K, Ryu S, Chang Y, et al
    High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men.
    PLoS One. 2017;12:e0172666.
    PubMed     Text format     Abstract available


  59. WU PY, Cheng CY, Liu CE, Lee YC, et al
    Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naive HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan.
    PLoS One. 2017;12:e0171596.
    PubMed     Text format     Abstract available


  60. PRAJAPATI HJ, Kim HS
    Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization.
    PLoS One. 2017;12:e0170750.
    PubMed     Text format     Abstract available


  61. TAI CS, Lin YR, Teng TH, Lin PY, et al
    Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma.
    PLoS One. 2017;12:e0171269.
    PubMed     Text format     Abstract available


  62. VAN DEN BERG EH, Amini M, Schreuder TC, Dullaart RP, et al
    Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
    PLoS One. 2017;12:e0171502.
    PubMed     Text format     Abstract available


  63. LACOSTE B, Raymond VA, Cassim S, Lapierre P, et al
    Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties.
    PLoS One. 2017;12:e0171215.
    PubMed     Text format     Abstract available


  64. KAJI K, Mizukoshi E, Yamashita T, Arai K, et al
    Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0170291.
    PubMed     Text format     Abstract available


  65. CHENG SB, Liu HT, Chen SY, Lin PT, et al
    Changes of Oxidative Stress, Glutathione, and Its Dependent Antioxidant Enzyme Activities in Patients with Hepatocellular Carcinoma before and after Tumor Resection.
    PLoS One. 2017;12:e0170016.
    PubMed     Text format     Abstract available


  66. LI C, Ni J, Liu YX, Wang H, et al
    Response of MiRNA-22-3p and MiRNA-149-5p to Folate Deficiency and the Differential Regulation of MTHFR Expression in Normal and Cancerous Human Hepatocytes.
    PLoS One. 2017;12:e0168049.
    PubMed     Text format     Abstract available


  67. YOO HJ, Hwang SY, Choi JH, Lee HJ, et al
    Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis.
    PLoS One. 2017;12:e0174717.
    PubMed     Text format     Abstract available


  68. TAKAHASHI A, Kono S, Wada A, Oshima S, et al
    Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy.
    PLoS One. 2017;12:e0174169.
    PubMed     Text format     Abstract available


  69. KOMIYAMA Y, Kurosaki M, Nakanishi H, Takahashi Y, et al
    Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio.
    PLoS One. 2017;12:e0174649.
    PubMed     Text format     Abstract available


  70. LEE M, Jo A, Lee S, Kim JB, et al
    3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0174271.
    PubMed     Text format     Abstract available


  71. GAO B, Zhang X, Huang Y, Yang Z, et al
    Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis.
    PLoS One. 2017;12:e0174142.
    PubMed     Text format     Abstract available


  72. JIN X, Liu J, Chen YP, Xiang Z, et al
    Effect of miR-146 targeted HDMCP up-regulation in the pathogenesis of nonalcoholic steatohepatitis.
    PLoS One. 2017;12:e0174218.
    PubMed     Text format     Abstract available


  73. LI Y, Dong Y, Huang Z, Kuang Q, et al
    Computational identifying and characterizing circular RNAs and their associated genes in hepatocellular carcinoma.
    PLoS One. 2017;12:e0174436.
    PubMed     Text format     Abstract available


  74. STRATIGOPOULOU P, Paul A, Hoyer DP, Kykalos S, et al
    High MELD score and extended operating time predict prolonged initial ICU stay after liver transplantation and influence the outcome.
    PLoS One. 2017;12:e0174173.
    PubMed     Text format     Abstract available


  75. LEE JS, Yoo JE, Kim H, Rhee H, et al
    Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma.
    PLoS One. 2017;12:e0171922.
    PubMed     Text format     Abstract available


  76. WANG Y, Stewart E, Desjardins L, Hadway J, et al
    Assessment of intratumor hypoxia by integrated 18F-FDG PET / perfusion CT in a liver tumor model.
    PLoS One. 2017;12:e0173016.
    PubMed     Text format     Abstract available


  77. DIJKSTRA H, Wolff D, van Melle JP, Bartelds B, et al
    Diminished liver microperfusion in Fontan patients: A biexponential DWI study.
    PLoS One. 2017;12:e0173149.
    PubMed     Text format     Abstract available


  78. LEDE V, Meusel A, Garten A, Popkova Y, et al
    Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor.
    PLoS One. 2017;12:e0172000.
    PubMed     Text format     Abstract available


  79. WU L, Pang Y, Qin G, Xi G, et al
    Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives.
    PLoS One. 2017;12:e0171840.
    PubMed     Text format     Abstract available


  80. ZHU Z, Tran H, Mathahs MM, Moninger TO, et al
    HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.
    PLoS One. 2017;12:e0166853.
    PubMed     Text format     Abstract available


  81. LEE SM, Lee JM, Kang HJ, Yang HK, et al
    Liver fibrosis staging with a new 2D-shear wave elastography using comb-push technique: Applicability, reproducibility, and diagnostic performance.
    PLoS One. 2017;12:e0177264.
    PubMed     Text format     Abstract available


  82. YANG C, Yang S, Xu W, Zhang J, et al
    Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study.
    PLoS One. 2017;12:e0177249.
    PubMed     Text format     Abstract available


  83. HUANG JF, Yeh ML, Huang CF, Huang CI, et al
    Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients.
    PLoS One. 2017;12:e0174394.
    PubMed     Text format     Abstract available


  84. ZHANG S, Xiao Q, Shi Z, Yu G, et al
    Caspase polymorphisms and prognosis of hepatocellular carcinoma.
    PLoS One. 2017;12:e0176802.
    PubMed     Text format     Abstract available


  85. RUEDA-ZARATE HA, Imaz-Rosshandler I, Cardenas-Ovando RA, Castillo-Fernandez JE, et al
    A computational toxicogenomics approach identifies a list of highly hepatotoxic compounds from a large microarray database.
    PLoS One. 2017;12:e0176284.
    PubMed     Text format     Abstract available


  86. NAOUR S, Espinoza BM, Aedo JE, Zuloaga R, et al
    Transcriptomic analysis of the hepatic response to stress in the red cusk-eel (Genypterus chilensis): Insights into lipid metabolism, oxidative stress and liver steatosis.
    PLoS One. 2017;12:e0176447.
    PubMed     Text format     Abstract available


  87. CHANG W, Lee JM, Yoon JH, Lee DH, et al
    No-touch radiofrequency ablation using multiple electrodes: An in vivo comparison study of switching monopolar versus switching bipolar modes in porcine livers.
    PLoS One. 2017;12:e0176350.
    PubMed     Text format     Abstract available


  88. ROKUSZ A, Veres D, Szucs A, Bugyik E, et al
    Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models.
    PLoS One. 2017;12:e0176518.
    PubMed     Text format     Abstract available


  89. ADEJUMO AC, Alliu S, Ajayi TO, Adejumo KL, et al
    Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.
    PLoS One. 2017;12:e0176416.
    PubMed     Text format     Abstract available


  90. OLDRINI G, Huertas A, Renard-Oldrini S, Taste-George H, et al
    Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma.
    PLoS One. 2017;12:e0176118.
    PubMed     Text format     Abstract available


  91. ESTIU MC, Frailuna MA, Otero C, Dericco M, et al
    Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid.
    PLoS One. 2017;12:e0176504.
    PubMed     Text format     Abstract available


  92. YEN YH, Chen JB, Cheng BC, Chen JF, et al
    Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study.
    PLoS One. 2017;12:e0176027.
    PubMed     Text format     Abstract available


  93. LEE HL, Cheng HL, Liu YF, Chou MC, et al
    Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.
    PLoS One. 2017;12:e0176141.
    PubMed     Text format     Abstract available


  94. YANG KL, Chang WT, Hong MY, Hung KC, et al
    Prevention of TGF-beta-induced early liver fibrosis by a maleic acid derivative anti-oxidant through suppression of ROS, inflammation and hepatic stellate cells activation.
    PLoS One. 2017;12:e0174008.
    PubMed     Text format     Abstract available


  95. LAHTI S, Ludwig JM, Xing M, Sun L, et al
    In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma-A pilot study.
    PLoS One. 2017;12:e0174539.
    PubMed     Text format     Abstract available


  96. CHAN M, Chiang CL, Lee V, Cheung S, et al
    Target localization of 3D versus 4D cone beam computed tomography in lipiodol-guided stereotactic radiotherapy of hepatocellular carcinomas.
    PLoS One. 2017;12:e0174929.
    PubMed     Text format     Abstract available


  97. PEYROUX E, Santaella N, Broussolle E, Rigard C, et al
    Social cognition in Wilson's disease: A new phenotype?
    PLoS One. 2017;12:e0173467.
    PubMed     Text format     Abstract available


  98. HERRADOR Z, Fernandez-Martinez A, Gomez-Barroso D, Leon I, et al
    Mediterranean spotted fever in Spain, 1997-2014: Epidemiological situation based on hospitalization records.
    PLoS One. 2017;12:e0174745.
    PubMed     Text format     Abstract available


  99. HE CB, Lin XJ
    Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
    PLoS One. 2017;12:e0174769.
    PubMed     Text format     Abstract available


  100. CHU YW, Lin HM, Wang JJ, Weng SF, et al
    Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: A national cohort study.
    PLoS One. 2017;12:e0174601.
    PubMed     Text format     Abstract available


  101. WANG YC, Chou CT, Lin CP, Chen YL, et al
    The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    PLoS One. 2017;12:e0174594.
    PubMed     Text format     Abstract available


  102. LI Y, Wang J, Tang Y, Han X, et al
    Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study.
    PLoS One. 2017;12:e0174291.
    PubMed     Text format     Abstract available


  103. KRAWCZYK M, Zimmermann S, Hess G, Holz R, et al
    Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease.
    PLoS One. 2017;12:e0173506.
    PubMed     Text format     Abstract available


  104. SONG YN, Dong S, Wei B, Liu P, et al
    Metabolomic mechanisms of gypenoside against liver fibrosis in rats: An integrative analysis of proteomics and metabolomics data.
    PLoS One. 2017;12:e0173598.
    PubMed     Text format     Abstract available


  105. VALBUSA F, Bonapace S, Agnoletti D, Scala L, et al
    Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.
    PLoS One. 2017;12:e0173398.
    PubMed     Text format     Abstract available


  106. HAGLUND S, Vikingsson S, Almer S, Soderman J, et al
    Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells - Effects on gene expression levels and thiopurine metabolism.
    PLoS One. 2017;12:e0173825.
    PubMed     Text format     Abstract available


  107. TAKAHARA I, Akazawa Y, Tabuchi M, Matsuda K, et al
    Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
    PLoS One. 2017;12:e0170591.
    PubMed     Text format     Abstract available


  108. WILMAN HR, Kelly M, Garratt S, Matthews PM, et al
    Characterisation of liver fat in the UK Biobank cohort.
    PLoS One. 2017;12:e0172921.
    PubMed     Text format     Abstract available


  109. WEN YF, Yang XZ, Zeng LS, Peng HH, et al
    Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma.
    PLoS One. 2017;12:e0172345.
    PubMed     Text format     Abstract available


  110. XUE M, Liu Y, Lyu R, Ge N, et al
    Protective effect of aplysin on liver tissue and the gut microbiota in alcohol-fed rats.
    PLoS One. 2017;12:e0178684.
    PubMed     Text format     Abstract available


  111. JOLY P, Vignaud H, Di Martino J, Ruiz M, et al
    ERAD defects and the HFE-H63D variant are associated with increased risk of liver damages in Alpha 1-Antitrypsin Deficiency.
    PLoS One. 2017;12:e0179369.
    PubMed     Text format     Abstract available


  112. RAO ZZ, Zhang XW, Ding YL, Yang MY, et al
    miR-148a-mediated estrogen-induced cholestasis in intrahepatic cholestasis of pregnancy: Role of PXR/MRP3.
    PLoS One. 2017;12:e0178702.
    PubMed     Text format     Abstract available


  113. SIGRUENER A, Wolfrum C, Boettcher A, Kopf T, et al
    Lipidomic and metabolic changes in the P4-type ATPase ATP10D deficient C57BL/6J wild type mice upon rescue of ATP10D function.
    PLoS One. 2017;12:e0178368.
    PubMed     Text format     Abstract available


  114. BUECHTER M, Kahraman A, Manka P, Gerken G, et al
    Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation.
    PLoS One. 2017;12:e0177401.
    PubMed     Text format     Abstract available


  115. PRIETO V, Ludwig JM, Farris AB, Nagaraju GP, et al
    Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study.
    PLoS One. 2017;12:e0177212.
    PubMed     Text format     Abstract available


  116. LAI LL, Chan WK, Sthaneshwar P, Nik Mustapha NR, et al
    Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0174982.
    PubMed     Text format     Abstract available


  117. ASTROM E, Stal P, Zenlander R, Edenvik P, et al
    Reverse lectin ELISA for detecting fucosylated forms of alpha1-acid glycoprotein associated with hepatocellular carcinoma.
    PLoS One. 2017;12:e0173897.
    PubMed     Text format     Abstract available


  118. HUH JH, Kim JY, Choi E, Kim JS, et al
    The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study.
    PLoS One. 2017;12:e0180951.
    PubMed     Text format     Abstract available


  119. LIU W, Li X, Zhou B, Fang S, et al
    Differential induction of apoptosis and autophagy by pyrrolizidine alkaloid clivorine in human hepatoma Huh-7.5 cells and its toxic implication.
    PLoS One. 2017;12:e0179379.
    PubMed     Text format     Abstract available


  120. PARK SH, Won HJ, Kim SY, Shin YM, et al
    Efficacy and safety of ultrasound-guided implantation of fiducial markers in the liver for stereotactic body radiation therapy.
    PLoS One. 2017;12:e0179676.
    PubMed     Text format     Abstract available


  121. GRANATA V, Fusco R, Catalano O, Avallone A, et al
    Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.
    PLoS One. 2017;12:e0179951.
    PubMed     Text format     Abstract available


  122. CHANG CC, Lee WS, Hsieh HG, Chuang CL, et al
    Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats.
    PLoS One. 2017;12:e0179809.
    PubMed     Text format     Abstract available


  123. PEREIRA ENGDS, Silvares RR, Flores EEI, Rodrigues KL, et al
    Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0179654.
    PubMed     Text format     Abstract available


  124. GAO B, Yu T, Xue D, Sun B, et al
    A multidimensional integration analysis reveals potential bridging targets in the process of colorectal cancer liver metastasis.
    PLoS One. 2017;12:e0178760.
    PubMed     Text format     Abstract available


  125. DOLD L, Luda C, Schwarze-Zander C, Boesecke C, et al
    Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).
    PLoS One. 2017;12:e0178685.
    PubMed     Text format     Abstract available


  126. NAKADE Y, Sakamoto K, Yamauchi T, Inoue T, et al
    Conophylline inhibits non-alcoholic steatohepatitis in mice.
    PLoS One. 2017;12:e0178436.
    PubMed     Text format     Abstract available


  127. CHANG YP, Chen YM, Lai CH, Lin CY, et al
    The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer.
    PLoS One. 2017;12:e0178676.
    PubMed     Text format     Abstract available


  128. HAN EC, Ryoo SB, Park JW, Yi JW, et al
    Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study.
    PLoS One. 2017;12:e0178920.
    PubMed     Text format     Abstract available


  129. ANDRIANTSOA M, Hoibian S, Autret A, Gilabert M, et al
    An elevated serum alkaline phosphatase level in hepatic metastases of grade 1 and 2 gastrointestinal neuroendocrine tumors is unusual and of prognostic value.
    PLoS One. 2017;12:e0177971.
    PubMed     Text format     Abstract available


  130. LO CH, Yang JF, Liu MY, Jen YM, et al
    Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy.
    PLoS One. 2017;12:e0177793.
    PubMed     Text format     Abstract available


  131. LIN WC, Lin HH, Hung CY, Shih SC, et al
    Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding.
    PLoS One. 2017;12:e0177449.
    PubMed     Text format     Abstract available


  132. KAFFARNIK MF, Ahmadi N, Lock JF, Wuensch T, et al
    Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study.
    PLoS One. 2017;12:e0178237.
    PubMed     Text format     Abstract available


  133. SORENSON EC, Khanin R, Bamboat ZM, Cavnar MJ, et al
    Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.
    PLoS One. 2017;12:e0176562.
    PubMed     Text format     Abstract available


  134. KREMERS RMW, Kleinegris MC, Ninivaggi M, de Laat B, et al
    Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis.
    PLoS One. 2017;12:e0177020.
    PubMed     Text format     Abstract available


  135. WANG C, Yang Y, Sun D, Jiang Y, et al
    Prognosis of hepatocellular carcinoma patients with bile duct tumor thrombus after hepatic resection or liver transplantation in Asian populations: A meta-analysis.
    PLoS One. 2017;12:e0176827.
    PubMed     Text format     Abstract available


  136. WONG MW, Chen MJ, Chen HL, Kuo YC, et al
    Application of chronic liver failure-sequential organ failure assessment score for the predication of mortality after esophageal variceal hemorrhage post endoscopic ligation.
    PLoS One. 2017;12:e0182529.
    PubMed     Text format     Abstract available


  137. LI SC, Lee CH, Hung CL, Wu JC, et al
    Surgical resection of metachronous hepatic metastases from gastric cancer improves long-term survival: A population-based study.
    PLoS One. 2017;12:e0182255.
    PubMed     Text format     Abstract available


  138. KIM G, Kim KJ, Rhee Y, Lim SK, et al
    Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0182202.
    PubMed     Text format     Abstract available


  139. HUA MC, Su HM, Yao TC, Kuo ML, et al
    Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis.
    PLoS One. 2017;12:e0182277.
    PubMed     Text format     Abstract available


  140. HUNG TH, Liang CM, Hsu CN, Tai WC, et al
    Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan.
    PLoS One. 2017;12:e0181858.
    PubMed     Text format     Abstract available


  141. LIU P, Xu Y, Tang Y, Du M, et al
    Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men.
    PLoS One. 2017;12:e0181497.
    PubMed     Text format     Abstract available


  142. SCHLEGEL V, Treuner-Kaueroff T, Seehofer D, Berg T, et al
    Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease.
    PLoS One. 2017;12:e0181540.
    PubMed     Text format     Abstract available


  143. GOEBEL J, Sulke M, Lazik-Palm A, Goebel T, et al
    Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma.
    PLoS One. 2017;12:e0181488.
    PubMed     Text format     Abstract available


  144. KAUFMANN B, Wang B, Zhong S, Laschinger M, et al
    BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness.
    PLoS One. 2017;12:e0180225.
    PubMed     Text format     Abstract available


  145. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    PubMed     Text format     Abstract available


  146. RISSIN DM, Lopez-Longarela B, Pernagallo S, Ilyine H, et al
    Polymerase-free measurement of microRNA-122 with single base specificity using single molecule arrays: Detection of drug-induced liver injury.
    PLoS One. 2017;12:e0179669.
    PubMed     Text format     Abstract available


  147. CAI G, Chen B, Li Z, Wei W, et al
    The different expressed serum proteins in rhCygb treated rat model of liver fibrosis by the optimized two-dimensional gel electrophoresis.
    PLoS One. 2017;12:e0177968.
    PubMed     Text format     Abstract available


  148. KAMMOUN HL, Allen TL, Henstridge DC, Kraakman MJ, et al
    Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice.
    PLoS One. 2017;12:e0179099.
    PubMed     Text format     Abstract available


  149. MATSUMOTO K, Ichimura M, Tsuneyama K, Moritoki Y, et al
    Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis.
    PLoS One. 2017;12:e0175406.
    PubMed     Text format     Abstract available


  150. KAMIMURA K, Yokoo T, Kamimura H, Sakamaki A, et al
    Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses.
    PLoS One. 2017;12:e0178991.
    PubMed     Text format     Abstract available


  151. KIM HM, Kim YM, Huh JH, Lee ES, et al
    alpha-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2.
    PLoS One. 2017;12:e0179204.
    PubMed     Text format     Abstract available


  152. KLOTTER V, Gunchick C, Siemers E, Rath T, et al
    Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study.
    PLoS One. 2017;12:e0178784.
    PubMed     Text format     Abstract available


  153. SOGABE M, Okahisa T, Nakasono M, Fukuno H, et al
    The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study.
    PLoS One. 2017;12:e0177925.
    PubMed     Text format     Abstract available


  154. HONG M, Jung J, Park HS, Lee SM, et al
    Shaofu Zhuyu decoction ameliorates obesity-mediated hepatic steatosis and systemic inflammation by regulating metabolic pathways.
    PLoS One. 2017;12:e0178514.
    PubMed     Text format     Abstract available


  155. HO SW, Yeh CB, Yang SF, Yeh HW, et al
    Pneumonia is an independent risk factor for pyogenic liver abscess: A population-based, nested, case-control study.
    PLoS One. 2017;12:e0178571.
    PubMed     Text format     Abstract available


  156. LI Z, Lin B, Lin G, Wu Y, et al
    Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis.
    PLoS One. 2017;12:e0178580.
    PubMed     Text format     Abstract available


  157. MASARONE M, Rosato V, Aglitti A, Bucci T, et al
    Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage.
    PLoS One. 2017;12:e0178473.
    PubMed     Text format     Abstract available


  158. LI M, Chen D, Huang H, Wang J, et al
    Caveolin1 protects against diet induced hepatic lipid accumulation in mice.
    PLoS One. 2017;12:e0178748.
    PubMed     Text format     Abstract available


  159. ZHENG H, Zou AE, Saad MA, Wang XQ, et al
    Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma.
    PLoS One. 2017;12:e0178547.
    PubMed     Text format     Abstract available


  160. OHNO Y, Koizumi M, Nakayama H, Watanabe T, et al
    Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma.
    PLoS One. 2017;12:e0177343.
    PubMed     Text format     Abstract available


  161. HAGA Y, Kanda T, Nakamura M, Nakamoto S, et al
    Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines.
    PLoS One. 2017;12:e0174153.
    PubMed     Text format     Abstract available


  162. JIA J, Qiao Y, Pilo MG, Cigliano A, et al
    Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.
    PLoS One. 2017;12:e0184068.
    PubMed     Text format     Abstract available


  163. HOU W, Gupta S, Beauchamp MC, Yuan L, et al
    Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2.
    PLoS One. 2017;12:e0182995.
    PubMed     Text format     Abstract available


  164. MATSUSHITA N, Hassanein MT, Martinez-Clemente M, Lazaro R, et al
    Gender difference in NASH susceptibility: Roles of hepatocyte Ikkbeta and Sult1e1.
    PLoS One. 2017;12:e0181052.
    PubMed     Text format     Abstract available


  165. CRUZ-BAQUERO A, Cardenas Jaramillo LM, Gutierrez-Meza M, Jarillo-Luna RA, et al
    Different behavior of myeloperoxidase in two rodent amoebic liver abscess models.
    PLoS One. 2017;12:e0182480.
    PubMed     Text format     Abstract available


  166. RODRIGUEZ K, Srivaths PR, Tal L, Watson MN, et al
    Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.
    PLoS One. 2017;12:e0182134.
    PubMed     Text format     Abstract available


  167. PINTER M, Haupt L, Hucke F, Bota S, et al
    The impact of thyroid hormones on patients with hepatocellular carcinoma.
    PLoS One. 2017;12:e0181878.
    PubMed     Text format     Abstract available


  168. XIMENEZ C, Gonzalez E, Nieves M, Magana U, et al
    Differential expression of pathogenic genes of Entamoeba histolytica vs E. dispar in a model of infection using human liver tissue explants.
    PLoS One. 2017;12:e0181962.
    PubMed     Text format     Abstract available


  169. ZHANG Y, Kim DK, Lu Y, Jung YS, et al
    Orphan nuclear receptor ERRgamma is a key regulator of human fibrinogen gene expression.
    PLoS One. 2017;12:e0182141.
    PubMed     Text format     Abstract available


  170. DUCHEIX S, Montagner A, Polizzi A, Lasserre F, et al
    Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling.
    PLoS One. 2017;12:e0181393.
    PubMed     Text format     Abstract available


  171. GASLJEVIC G, Edhemovic I, Cemazar M, Brecelj E, et al
    Histopathological findings in colorectal liver metastases after electrochemotherapy.
    PLoS One. 2017;12:e0180709.
    PubMed     Text format     Abstract available


  172. KIM J, Lee DY, Park SE, Park CY, et al
    Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation.
    PLoS One. 2017;12:e0180118.
    PubMed     Text format     Abstract available


  173. YU J, Yang X, Luo Y, Yang X, et al
    Adverse effects of chronic exposure to nonylphenol on non-alcoholic fatty liver disease in male rats.
    PLoS One. 2017;12:e0180218.
    PubMed     Text format     Abstract available


  174. SCHOEMAKER MH, Kleemann R, Morrison MC, Verheij J, et al
    A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.
    PLoS One. 2017;12:e0180648.
    PubMed     Text format     Abstract available


  175. KONG E, Chun KA, Cho IH
    Quantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: Correlation between glucose metabolism and apparent diffusion coefficient.
    PLoS One. 2017;12:e0180184.
    PubMed     Text format     Abstract available


  176. HO SY, Liu PH, Hsu CY, Hsia CY, et al
    Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    PLoS One. 2017;12:e0180408.
    PubMed     Text format     Abstract available


  177. YEN CH, Wang KT, Lee PY, Liu CC, et al
    Gender-differences in the associations between circulating creatine kinase, blood pressure, body mass and non-alcoholic fatty liver disease in asymptomatic asians.
    PLoS One. 2017;12:e0179898.
    PubMed     Text format     Abstract available


  178. PRESTIGIACOMO V, Weston A, Messner S, Lampart F, et al
    Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis.
    PLoS One. 2017;12:e0179995.
    PubMed     Text format     Abstract available


  179. KANAMORI H, Nakade Y, Yamauchi T, Sakamoto K, et al
    Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats.
    PLoS One. 2017;12:e0180475.
    PubMed     Text format     Abstract available


  180. BAE JS, Kim JH, Yu MH, Lee DH, et al
    Diagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS).
    PLoS One. 2017;12:e0178495.
    PubMed     Text format     Abstract available


  181. ZENG T, Wang D, Chen J, Tian Y, et al
    LncRNA-AF113014 promotes the expression of Egr2 by interaction with miR-20a to inhibit proliferation of hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0177843.
    PubMed     Text format     Abstract available


  182. YANG YJ, Bang CS, Shin SP, Baik GH, et al
    Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.
    PLoS One. 2017;12:e0182014.
    PubMed     Text format     Abstract available


    January 2016
  183. ISHIKAWA T, Abe S, Hoshii A, Yamada Y, et al
    Cone-Beam Computed Tomography Correlates with Conventional Helical Computed Tomography in Evaluation of Lipiodol Accumulation in HCC after Chemoembolization.
    PLoS One. 2016;11:e0145546.
    PubMed     Text format     Abstract available


  184. THOMSEN KL, Macnaughtan J, Tritto G, Mookerjee RP, et al
    Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy.
    PLoS One. 2016;11:e0146076.
    PubMed     Text format     Abstract available


  185. POGGIOGALLE E, Lubrano C, Gnessi L, Mariani S, et al
    Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects.
    PLoS One. 2016;11:e0145811.
    PubMed     Text format     Abstract available


  186. LV H, Zhang Z, Wu X, Wang Y, et al
    Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent.
    PLoS One. 2016;11:e0145195.
    PubMed     Text format     Abstract available


  187. YANO S, Takehara K, Miwa S, Kishimoto H, et al
    Improved Resection and Outcome of Colon-Cancer Liver Metastasis with Fluorescence-Guided Surgery Using In Situ GFP Labeling with a Telomerase-Dependent Adenovirus in an Orthotopic Mouse Model.
    PLoS One. 2016;11:e0148760.
    PubMed     Text format     Abstract available


  188. ZHANG B, Liang L, Dong Y, Lian Z, et al
    Intravoxel Incoherent Motion MR Imaging for Staging of Hepatic Fibrosis.
    PLoS One. 2016;11:e0147789.
    PubMed     Text format     Abstract available


  189. LI TH, Huang CC, Yang YY, Lee KC, et al
    Thalidomide Improves the Intestinal Mucosal Injury and Suppresses Mesenteric Angiogenesis and Vasodilatation by Down-Regulating Inflammasomes-Related Cascades in Cirrhotic Rats.
    PLoS One. 2016;11:e0147212.
    PubMed     Text format     Abstract available


  190. LU S, Natarajan SK, Mott JL, Kharbanda KK, et al
    Ceramide Induces Human Hepcidin Gene Transcription through JAK/STAT3 Pathway.
    PLoS One. 2016;11:e0147474.
    PubMed     Text format     Abstract available


  191. SANTOS-LOPEZ JA, Garcimartin A, Merino P, Lopez-Oliva ME, et al
    Effects of Silicon vs. Hydroxytyrosol-Enriched Restructured Pork on Liver Oxidation Status of Aged Rats Fed High-Saturated/High-Cholesterol Diets.
    PLoS One. 2016;11:e0147469.
    PubMed     Text format     Abstract available


  192. KIM TY, Song do S, Kim HY, Sinn DH, et al
    Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition.
    PLoS One. 2016;11:e0146745.
    PubMed     Text format     Abstract available


  193. URASAKI Y, Pizzorno G, Le TT
    Chronic Uridine Administration Induces Fatty Liver and Pre-Diabetic Conditions in Mice.
    PLoS One. 2016;11:e0146994.
    PubMed     Text format     Abstract available


  194. LYTLE KA, Jump DB
    Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
    PLoS One. 2016;11:e0146942.
    PubMed     Text format     Abstract available


  195. LEE EJ, Lee SJ, Kim JH, Kim KJ, et al
    Radiation Inhibits Interleukin-12 Production via Inhibition of C-Rel through the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Signaling Pathway in Dendritic Cells.
    PLoS One. 2016;11:e0146463.
    PubMed     Text format     Abstract available


  196. WADA Y, Takami Y, Tateishi M, Ryu T, et al
    The Efficacy of Continued Sorafenib Treatment after Radiologic Confirmation of Progressive Disease in Patients with Advanced Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0146456.
    PubMed     Text format     Abstract available


  197. MORO T, Nakao S, Sumiyoshi H, Ishii T, et al
    A Combination of Mitochondrial Oxidative Stress and Excess Fat/Calorie Intake Accelerates Steatohepatitis by Enhancing Hepatic CC Chemokine Production in Mice.
    PLoS One. 2016;11:e0146592.
    PubMed     Text format     Abstract available


  198. PEREPELYUK M, Chin L, Cao X, van Oosten A, et al
    Normal and Fibrotic Rat Livers Demonstrate Shear Strain Softening and Compression Stiffening: A Model for Soft Tissue Mechanics.
    PLoS One. 2016;11:e0146588.
    PubMed     Text format     Abstract available


  199. CHEN Y, Wang W, Wang H, Li Y, et al
    Rapamycin Attenuates Splenomegaly in both Intrahepatic and Prehepatic Portal Hypertensive Rats by Blocking mTOR Signaling Pathway.
    PLoS One. 2016;11:e0141159.
    PubMed     Text format     Abstract available


  200. HONDA Y, Imajo K, Kato T, Kessoku T, et al
    The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice.
    PLoS One. 2016;11:e0146337.
    PubMed     Text format     Abstract available


  201. PARK JY, Murakami T, Lee JY, Zhang Y, et al
    Fluorescent-Antibody Targeting of Insulin-Like Growth Factor-1 Receptor Visualizes Metastatic Human Colon Cancer in Orthotopic Mouse Models.
    PLoS One. 2016;11:e0146504.
    PubMed     Text format     Abstract available


  202. SHIBATA Y, Hara T, Nagano J, Nakamura N, et al
    The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
    PLoS One. 2016;11:e0146279.
    PubMed     Text format     Abstract available


  203. TAMADA H, Naito H, Kitamori K, Hayashi Y, et al
    Efficacy of Dietary Lipid Control in Healing High-Fat and High-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats.
    PLoS One. 2016;11:e0145939.
    PubMed     Text format     Abstract available


  204. FEIERSINGER F, Nolte E, Wach S, Rau TT, et al
    MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma.
    PLoS One. 2016;11:e0148580.
    PubMed     Text format     Abstract available


  205. RAO Q, You A, Guo Z, Zuo B, et al
    Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models.
    PLoS One. 2016;11:e0148263.
    PubMed     Text format     Abstract available


  206. STACCHIOTTI A, Favero G, Lavazza A, Golic I, et al
    Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0148115.
    PubMed     Text format     Abstract available


  207. KUMAR S, Wang J, Rani R, Gandhi CR, et al
    Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in Mice.
    PLoS One. 2016;11:e0147864.
    PubMed     Text format     Abstract available


  208. PIRHONEN J, Arola J, Sadevirta S, Luukkonen P, et al
    Continuous Grading of Early Fibrosis in NAFLD Using Label-Free Imaging: A Proof-of-Concept Study.
    PLoS One. 2016;11:e0147804.
    PubMed     Text format     Abstract available


  209. COOPER DA, Cordery DV, Zajdenverg R, Ruxrungtham K, et al
    Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naive HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial.
    PLoS One. 2016;11:e0144917.
    PubMed     Text format     Abstract available


  210. SREEKANTH GP, Chuncharunee A, Sirimontaporn A, Panaampon J, et al
    SB203580 Modulates p38 MAPK Signaling and Dengue Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2 Phosphorylation.
    PLoS One. 2016;11:e0149486.
    PubMed     Text format     Abstract available


  211. YAO L, Abe M, Kawasaki K, Akbar SM, et al
    Characterization of Liver Monocytic Myeloid-Derived Suppressor Cells and Their Role in a Murine Model of Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0149948.
    PubMed     Text format     Abstract available


  212. JIANG Y, Li J, Wang J, Xiao H, et al
    Assessment of Vascularity in Hepatic Alveolar Echinococcosis: Comparison of Quantified Dual-Energy CT with Histopathologic Parameters.
    PLoS One. 2016;11:e0149440.
    PubMed     Text format     Abstract available


  213. GAO J, Ji JS, Ding XM, Ke S, et al
    Laparoscopic Radiofrequency Ablation for Large Subcapsular Hepatic Hemangiomas: Technical and Clinical Outcomes.
    PLoS One. 2016;11:e0149755.
    PubMed     Text format     Abstract available


  214. KUO YT, Chen CY, Liu GC, Wang YM, et al
    Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
    PLoS One. 2016;11:e0148695.
    PubMed     Text format     Abstract available


  215. KIM SB, Kang OH, Lee YS, Han SH, et al
    Hepatoprotective Effect and Synergism of Bisdemethoycurcumin against MCD Diet-Induced Nonalcoholic Fatty Liver Disease in Mice.
    PLoS One. 2016;11:e0147745.
    PubMed     Text format     Abstract available


  216. FAN X, Zhang X, Shen J, Zhao H, et al
    Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis.
    PLoS One. 2016;11:e0149028.
    PubMed     Text format     Abstract available


  217. PETROPOLIS DB, Faust DM, Tolle M, Riviere L, et al
    Human Liver Infection in a Dish: Easy-To-Build 3D Liver Models for Studying Microbial Infection.
    PLoS One. 2016;11:e0148667.
    PubMed     Text format     Abstract available


  218. FUJIMOTO Y, Urashima T, Shimura D, Ito R, et al
    Low Cardiac Output Leads Hepatic Fibrosis in Right Heart Failure Model Rats.
    PLoS One. 2016;11:e0148666.
    PubMed     Text format     Abstract available


  219. XU J, Sayed BA, Casas-Ferreira AM, Srinivasan P, et al
    The Impact of Ischemia/Reperfusion Injury on Liver Allografts from Deceased after Cardiac Death versus Deceased after Brain Death Donors.
    PLoS One. 2016;11:e0148815.
    PubMed     Text format     Abstract available


  220. CARLSON N, Hommel K, Olesen JB, Soja AM, et al
    Dialysis-Requiring Acute Kidney Injury in Denmark 2000-2012: Time Trends of Incidence and Prevalence of Risk Factors-A Nationwide Study.
    PLoS One. 2016;11:e0148809.
    PubMed     Text format     Abstract available


  221. WEI J, Lei GH, Fu L, Zeng C, et al
    Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults.
    PLoS One. 2016;11:e0147985.
    PubMed     Text format     Abstract available


  222. HANADA S, Iwata S, Kishi K, Morozumi M, et al
    Host Factors and Biomarkers Associated with Poor Outcomes in Adults with Invasive Pneumococcal Disease.
    PLoS One. 2016;11:e0147877.
    PubMed     Text format     Abstract available


  223. VENKATESAN N, Kanwar J, Deepa PR, Khetan V, et al
    Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.
    PLoS One. 2016;11:e0146128.
    PubMed     Text format     Abstract available


  224. SHAO J, Xu Z, Peng X, Chen M, et al
    Gefitinib Synergizes with Irinotecan to Suppress Hepatocellular Carcinoma via Antagonizing Rad51-Mediated DNA-Repair.
    PLoS One. 2016;11:e0146968.
    PubMed     Text format     Abstract available


  225. ISHIDA T, Kotani H, Miyao M, Kawai C, et al
    Renal Impairment with Sublethal Tubular Cell Injury in a Chronic Liver Disease Mouse Model.
    PLoS One. 2016;11:e0146871.
    PubMed     Text format     Abstract available


  226. ANURACPREEDA P, Chawengkirttikul R, Sobhon P
    Immunodiagnosis of Fasciola gigantica Infection Using Monoclonal Antibody-Based Sandwich ELISA and Immunochromatographic Assay for Detection of Circulating Cathepsin L1 Protease.
    PLoS One. 2016;11:e0145650.
    PubMed     Text format     Abstract available


  227. ULITZKY L, Lafer MM, KuKuruga MA, Silberstein E, et al
    A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9.
    PLoS One. 2016;11:e0145212.
    PubMed     Text format     Abstract available


  228. GARCES-RIMON M, Gonzalez C, Uranga JA, Lopez-Miranda V, et al
    Pepsin Egg White Hydrolysate Ameliorates Obesity-Related Oxidative Stress, Inflammation and Steatosis in Zucker Fatty Rats.
    PLoS One. 2016;11:e0151193.
    PubMed     Text format     Abstract available


  229. LIU S, Xia Z, Liu J, Xu J, et al
    Automatic Multiple-Needle Surgical Planning of Robotic-Assisted Microwave Coagulation in Large Liver Tumor Therapy.
    PLoS One. 2016;11:e0149482.
    PubMed     Text format     Abstract available


  230. KOMIYA C, Tsuchiya K, Shiba K, Miyachi Y, et al
    Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
    PLoS One. 2016;11:e0151511.
    PubMed     Text format     Abstract available


  231. FENG J, Zhu R, Chang C, Yu L, et al
    CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.
    PLoS One. 2016;11:e0151501.
    PubMed     Text format     Abstract available


  232. JIAO J, Watt GP, Lee M, Rahbar MH, et al
    Cirrhosis and Advanced Fibrosis in Hispanics in Texas: The Dominant Contribution of Central Obesity.
    PLoS One. 2016;11:e0150978.
    PubMed     Text format     Abstract available


  233. VERHAAG EM, Buist-Homan M, Koehorst M, Groen AK, et al
    Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity.
    PLoS One. 2016;11:e0149782.
    PubMed     Text format     Abstract available


  234. HELLING G, Wahlin S, Smedberg M, Pettersson L, et al
    Plasma Glutamine Concentrations in Liver Failure.
    PLoS One. 2016;11:e0150440.
    PubMed     Text format     Abstract available


  235. ZWOLAK A, Slabczynska O, Semeniuk J, Daniluk J, et al
    Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo Studies.
    PLoS One. 2016;11:e0150233.
    PubMed     Text format     Abstract available


  236. KNIGHT SR, Oniscu GC, Devey L, Simpson KJ, et al
    Use of Renal Replacement Therapy May Influence Graft Outcomes following Liver Transplantation for Acute Liver Failure: A Propensity-Score Matched Population-Based Retrospective Cohort Study.
    PLoS One. 2016;11:e0148782.
    PubMed     Text format     Abstract available


  237. ZENG T, Zhou J, He L, Zheng J, et al
    Blocking Nuclear Factor-Kappa B Protects against Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice.
    PLoS One. 2016;11:e0149677.
    PubMed     Text format     Abstract available


  238. TAPPER EB, Hunink MG, Afdhal NH, Lai M, et al
    Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.
    PLoS One. 2016;11:e0147237.
    PubMed     Text format     Abstract available


  239. HWANG SM, Jeon TY, Yoo SY, Kim JH, et al
    Alagille Syndrome Candidates for Liver Transplantation: Differentiation from End-Stage Biliary Atresia Using Preoperative CT.
    PLoS One. 2016;11:e0149681.
    PubMed     Text format     Abstract available


  240. VASQUES ER, Cunha JE, Coelho AM, Sampietre SN, et al
    Trisulfate Disaccharide Decreases Calcium Overload and Protects Liver Injury Secondary to Liver Ischemia/Reperfusion.
    PLoS One. 2016;11:e0149630.
    PubMed     Text format     Abstract available


  241. HAMETNER S, Ferlitsch A, Ferlitsch M, Etschmaier A, et al
    The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.
    PLoS One. 2016;11:e0149230.
    PubMed     Text format     Abstract available


  242. ARAUJO JUNIOR RF, Garcia VB, Leitao RF, Brito GA, et al
    Carvedilol Improves Inflammatory Response, Oxidative Stress and Fibrosis in the Alcohol-Induced Liver Injury in Rats by Regulating Kuppfer Cells and Hepatic Stellate Cells.
    PLoS One. 2016;11:e0148868.
    PubMed     Text format     Abstract available


  243. TAN Y, Liu X, Zhou K, He X, et al
    The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia.
    PLoS One. 2016;11:e0149043.
    PubMed     Text format     Abstract available


  244. SU YC, Davuluri GV, Chen CH, Shiau DC, et al
    Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0148408.
    PubMed     Text format     Abstract available


  245. BONDE Y, Eggertsen G, Rudling M
    Mice Abundant in Muricholic Bile Acids Show Resistance to Dietary Induced Steatosis, Weight Gain, and to Impaired Glucose Metabolism.
    PLoS One. 2016;11:e0147772.
    PubMed     Text format     Abstract available


  246. YUAN P, Cao JL, Abuduwufuer A, Wang LM, et al
    Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis.
    PLoS One. 2016;11:e0146803.
    PubMed     Text format     Abstract available


  247. BAUMGART DC, le Claire M
    The Expenditures for Academic Inpatient Care of Inflammatory Bowel Disease Patients Are Almost Double Compared with Average Academic Gastroenterology and Hepatology Cases and Not Fully Recovered by Diagnosis-Related Group (DRG) Proceeds.
    PLoS One. 2016;11:e0147364.
    PubMed     Text format     Abstract available


  248. KONGKAVITOON P, Tangkijvanich P, Hirankarn N, Palaga T, et al
    Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0146696.
    PubMed     Text format     Abstract available


  249. ITO H, Tanaka S, Akiyama Y, Shimada S, et al
    Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis.
    PLoS One. 2016;11:e0146564.
    PubMed     Text format     Abstract available


  250. LI M, Ye T, Wang XX, Li X, et al
    Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats.
    PLoS One. 2016;11:e0152085.
    PubMed     Text format     Abstract available


  251. ALT Y, Grimm A, Schlegel L, Grambihler A, et al
    The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease.
    PLoS One. 2016;11:e0151200.
    PubMed     Text format     Abstract available


  252. JANG ES, Jeong SH, Kim JW, Choi YS, et al
    Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0151069.
    PubMed     Text format     Abstract available


  253. NALPAS B, Ichai P, Jamot L, Carbonell N, et al
    A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases.
    PLoS One. 2016;11:e0150733.
    PubMed     Text format     Abstract available


  254. CHEN QF, Chen HJ, Liu J, Sun T, et al
    Machine Learning Classification of Cirrhotic Patients with and without Minimal Hepatic Encephalopathy Based on Regional Homogeneity of Intrinsic Brain Activity.
    PLoS One. 2016;11:e0151263.
    PubMed     Text format     Abstract available


  255. NAKAYAMA Y, Yamaguchi H, Einaga N, Esumi M, et al
    Pitfalls of DNA Quantification Using DNA-Binding Fluorescent Dyes and Suggested Solutions.
    PLoS One. 2016;11:e0150528.
    PubMed     Text format     Abstract available


  256. SIEGMUND SV, Schlosser M, Schildberg FA, Seki E, et al
    Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells.
    PLoS One. 2016;11:e0150893.
    PubMed     Text format     Abstract available


  257. ARYAL B, Shimizu T, Kadono J, Furoi A, et al
    A Switch in the Dynamics of Intra-Platelet VEGF-A from Cancer to the Later Phase of Liver Regeneration after Partial Hepatectomy in Humans.
    PLoS One. 2016;11:e0150446.
    PubMed     Text format     Abstract available


  258. SONG H, Zheng Z, Wu J, Lai J, et al
    White Pitaya (Hylocereus undatus) Juice Attenuates Insulin Resistance and Hepatic Steatosis in Diet-Induced Obese Mice.
    PLoS One. 2016;11:e0149670.
    PubMed     Text format     Abstract available


  259. URANBILEG B, Ikeda H, Kurano M, Enooku K, et al
    Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence.
    PLoS One. 2016;11:e0149462.
    PubMed     Text format     Abstract available


  260. HIROOKA M, Koizumi Y, Imai Y, Miyake T, et al
    Usefulness of a New Three-Dimensional Simulator System for Radiofrequency Ablation.
    PLoS One. 2016;11:e0148298.
    PubMed     Text format     Abstract available


  261. OMAR HA, Mohamed WR, Arab HH, Arafa el-SA, et al
    Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis.
    PLoS One. 2016;11:e0151649.
    PubMed     Text format     Abstract available


  262. ROMAN E, Garcia-Galceran C, Torrades T, Herrera S, et al
    Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical Trial.
    PLoS One. 2016;11:e0151652.
    PubMed     Text format     Abstract available


  263. TANG L, Zhu H, Yang X, Xie F, et al
    Shizukaol D, a Dimeric Sesquiterpene Isolated from Chloranthus serratus, Represses the Growth of Human Liver Cancer Cells by Modulating Wnt Signalling Pathway.
    PLoS One. 2016;11:e0152012.
    PubMed     Text format     Abstract available


  264. PREUSSE M, Theis FJ, Mueller NS
    miTALOS v2: Analyzing Tissue Specific microRNA Function.
    PLoS One. 2016;11:e0151771.
    PubMed     Text format     Abstract available


  265. CHOW LN, Schreiner P, Ng BY, Lo B, et al
    Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice.
    PLoS One. 2016;11:e0151765.
    PubMed     Text format     Abstract available


  266. BAIOCCHINI A, Montaldo C, Conigliaro A, Grimaldi A, et al
    Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution.
    PLoS One. 2016;11:e0151736.
    PubMed     Text format     Abstract available


  267. ZHANG X, Wang Y, Han S, Xiang H, et al
    RY10-4 Inhibits the Proliferation of Human Hepatocellular Cancer HepG2 Cells by Inducing Apoptosis In Vitro and In Vivo.
    PLoS One. 2016;11:e0151679.
    PubMed     Text format     Abstract available


  268. FUJIBAYASHI K, Gunji T, Yokokawa H, Naito T, et al
    The Relationships between Metabolic Disorders (Hypertension, Dyslipidemia, and Impaired Glucose Tolerance) and Computed Tomography-Based Indices of Hepatic Steatosis or Visceral Fat Accumulation in Middle-Aged Japanese Men.
    PLoS One. 2016;11:e0149689.
    PubMed     Text format     Abstract available


  269. ROY N, Dasgupta D, Mukhopadhyay I, Chatterjee A, et al
    Genetic Association and Gene-Gene Interaction Reveal Genetic Variations in ADH1B, GSTM1 and MnSOD Independently Confer Risk to Alcoholic Liver Diseases in India.
    PLoS One. 2016;11:e0149843.
    PubMed     Text format     Abstract available


  270. AGEBRATT C, Strom E, Romu T, Dahlqvist-Leinhard O, et al
    A Randomized Study of the Effects of Additional Fruit and Nuts Consumption on Hepatic Fat Content, Cardiovascular Risk Factors and Basal Metabolic Rate.
    PLoS One. 2016;11:e0147149.
    PubMed     Text format     Abstract available


  271. TANG Y, Lv P, Sun Z, Han L, et al
    14-3-3beta Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells by Modulating Expression of MMP2 and MMP9 through PI3K/Akt/NF-kappaB Pathway.
    PLoS One. 2016;11:e0146070.
    PubMed     Text format     Abstract available


  272. LI YL, Zhang J, Min D, Hongyan Z, et al
    Anticancer Effects of 1,3-Dihydroxy-2-Methylanthraquinone and the Ethyl Acetate Fraction of Hedyotis Diffusa Willd against HepG2 Carcinoma Cells Mediated via Apoptosis.
    PLoS One. 2016;11:e0151502.
    PubMed     Text format     Abstract available


  273. MATSUSHIMA-NISHIWAKI R, Toyoda H, Nagasawa T, Yasuda E, et al
    Phosphorylated Heat Shock Protein 20 (HSPB6) Regulates Transforming Growth Factor-alpha-Induced Migration and Invasion of Hepatocellular Carcinoma Cells.
    PLoS One. 2016;11:e0151907.
    PubMed     Text format     Abstract available


  274. NAWATA A, Noguchi H, Mazaki Y, Kurahashi T, et al
    Overexpression of Peroxiredoxin 4 Affects Intestinal Function in a Dietary Mouse Model of Nonalcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0152549.
    PubMed     Text format     Abstract available


  275. LI J, Chen K, Li S, Liu T, et al
    Pretreatment with Fucoidan from Fucus vesiculosus Protected against ConA-Induced Acute Liver Injury by Inhibiting Both Intrinsic and Extrinsic Apoptosis.
    PLoS One. 2016;11:e0152570.
    PubMed     Text format     Abstract available


  276. LAEMMLE A, Gallagher RC, Keogh A, Stricker T, et al
    Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD).
    PLoS One. 2016;11:e0153358.
    PubMed     Text format     Abstract available


  277. DASHTSOODOL N, Shigeura T, Ozawa R, Harada M, et al
    Generation of Novel Traj18-Deficient Mice Lacking Valpha14 Natural Killer T Cells with an Undisturbed T Cell Receptor alpha-Chain Repertoire.
    PLoS One. 2016;11:e0153347.
    PubMed     Text format     Abstract available


  278. ESTRELA HF, Damasio ES, Fonseca EK, Bergamaschi CT, et al
    Differential Sympathetic Vasomotor Activation Induced by Liver Cirrhosis in Rats.
    PLoS One. 2016;11:e0152512.
    PubMed     Text format     Abstract available


  279. HUAN H, Wen X, Chen X, Wu L, et al
    C/EBPalpha Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/beta-Catenin Signaling Mediated EMT.
    PLoS One. 2016;11:e0153117.
    PubMed     Text format     Abstract available


  280. GHAGHADA KB, Sato AF, Starosolski ZA, Berg J, et al
    Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer.
    PLoS One. 2016;11:e0152718.
    PubMed     Text format     Abstract available


  281. OKABE H, Kinoshita H, Imai K, Nakagawa S, et al
    Diverse Basis of beta-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis.
    PLoS One. 2016;11:e0152695.
    PubMed     Text format     Abstract available


  282. REN J, Chen GG, Liu Y, Su X, et al
    Cytochrome P450 1A2 Metabolizes 17beta-Estradiol to Suppress Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0153863.
    PubMed     Text format     Abstract available


  283. SALVOZA NC, Klinzing DC, Gopez-Cervantes J, Baclig MO, et al
    Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0153497.
    PubMed     Text format     Abstract available


  284. MONTALBANO M, Curcuru G, Shirafkan A, Vento R, et al
    Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion.
    PLoS One. 2016;11:e0153613.
    PubMed     Text format     Abstract available


  285. CHIU HW, Hua KF
    Hepatoprotective Effect of Wheat-Based Solid-State Fermented Antrodia cinnamomea in Carbon Tetrachloride-Induced Liver Injury in Rat.
    PLoS One. 2016;11:e0153087.
    PubMed     Text format     Abstract available


  286. JUNG J, Yoon SM, Park HC, Nam TK, et al
    Radiotherapy for Adrenal Metastasis from Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 13-05).
    PLoS One. 2016;11:e0152642.
    PubMed     Text format     Abstract available


  287. NANTASANTI S, Toussaint MJ, Youssef SA, Tooten PC, et al
    Rb and p53 Liver Functions Are Essential for Xenobiotic Metabolism and Tumor Suppression.
    PLoS One. 2016;11:e0150064.
    PubMed     Text format     Abstract available


  288. LI C, Li P, Tan YM, Lam SH, et al
    Metabolomic Characterizations of Liver Injury Caused by Acute Arsenic Toxicity in Zebrafish.
    PLoS One. 2016;11:e0151225.
    PubMed     Text format     Abstract available


  289. XIE F, Li ZP, Wang HW, Fei X, et al
    Evaluation of Liver Ischemia-Reperfusion Injury in Rabbits Using a Nanoscale Ultrasound Contrast Agent Targeting ICAM-1.
    PLoS One. 2016;11:e0153805.
    PubMed     Text format     Abstract available


  290. SHEARN CT, Orlicky DJ, McCullough RL, Jiang H, et al
    Liver-Specific Deletion of Phosphatase and Tensin Homolog Deleted on Chromosome 10 Significantly Ameliorates Chronic EtOH-Induced Increases in Hepatocellular Damage.
    PLoS One. 2016;11:e0154152.
    PubMed     Text format     Abstract available


  291. SANTAREM OL, Cleva Rd, Sasaya FM, Assumpcao MS, et al
    Left Ventricular Dilation and Pulmonary Vasodilatation after Surgical Shunt for Treatment of Pre-Sinusoidal Portal Hypertension.
    PLoS One. 2016;11:e0154011.
    PubMed     Text format     Abstract available


  292. SUN MY, Zhang L, Shi SL, Lin JN, et al
    Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.
    PLoS One. 2016;11:e0154337.
    PubMed     Text format     Abstract available


  293. MOUZAKI M, Wang AY, Bandsma R, Comelli EM, et al
    Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0151829.
    PubMed     Text format     Abstract available


  294. PAN C, Wang X, Shi K, Zheng Y, et al
    MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism.
    PLoS One. 2016;11:e0152090.
    PubMed     Text format     Abstract available


  295. ARAGONES G, Auguet T, Berlanga A, Guiu-Jurado E, et al
    Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0154601.
    PubMed     Text format     Abstract available


  296. CHIBA T, Suzuki S, Sato Y, Itoh T, et al
    Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.
    PLoS One. 2016;11:e0164191.
    PubMed     Text format     Abstract available


  297. EHLKEN H, Wroblewski R, Corpechot C, Arrive L, et al
    Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis.
    PLoS One. 2016;11:e0164224.
    PubMed     Text format     Abstract available


  298. LIU TL, Barritt Iv AS, Weinberger M, Paul JE, et al
    Who Treats Patients with Diabetes and Compensated Cirrhosis.
    PLoS One. 2016;11:e0165574.
    PubMed     Text format     Abstract available


  299. BOUTTELL J, Lewsey J, Geue C, Antony G, et al
    The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011.
    PLoS One. 2016;11:e0162980.
    PubMed     Text format     Abstract available


  300. AMARAL KB, Silva TP, Malta KK, Carmo LA, et al
    Natural Schistosoma mansoni Infection in the Wild Reservoir Nectomys squamipes Leads to Excessive Lipid Droplet Accumulation in Hepatocytes in the Absence of Liver Functional Impairment.
    PLoS One. 2016;11:e0166979.
    PubMed     Text format     Abstract available


  301. ZHENG S, Zhang P, Chen Y, Zheng S, et al
    Inhibition of Notch Signaling Attenuates Schistosomiasis Hepatic Fibrosis via Blocking Macrophage M2 Polarization.
    PLoS One. 2016;11:e0166808.
    PubMed     Text format     Abstract available


  302. HE XX, Wu XL, Chen RP, Chen C, et al
    Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0162368.
    PubMed     Text format     Abstract available


  303. CHENG CW, Liu FC, Lin JR, Tsai YF, et al
    The Impact of Hospital/Surgeon Volume on Acute Renal Failure and Mortality in Liver Transplantation: A Nationwide Cohort Study.
    PLoS One. 2016;11:e0162992.
    PubMed     Text format     Abstract available


  304. NOVO-VELEIRO I, Cieza-Borrella C, Pastor I, Chamorro AJ, et al
    A Single Nucleotide Polymorphism in the RASGRF2 Gene Is Associated with Alcoholic Liver Cirrhosis in Men.
    PLoS One. 2016;11:e0168685.
    PubMed     Text format     Abstract available


  305. TUTTOLOMONDO A, Di Raimondo D, Bellia C, Clemente G, et al
    Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites.
    PLoS One. 2016;11:e0165443.
    PubMed     Text format     Abstract available


  306. LECUBE A, Valladares S, Lopez-Cano C, Gutierrez L, et al
    The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori.
    PLoS One. 2016;11:e0166741.
    PubMed     Text format     Abstract available


  307. FAN WC, Liu CW, Ou SM, Huang CC, et al
    TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients.
    PLoS One. 2016;11:e0166458.
    PubMed     Text format     Abstract available


  308. FJELD K, Beer S, Johnstone M, Zimmer C, et al
    Length of Variable Numbers of Tandem Repeats in the Carboxyl Ester Lipase (CEL) Gene May Confer Susceptibility to Alcoholic Liver Cirrhosis but Not Alcoholic Chronic Pancreatitis.
    PLoS One. 2016;11:e0165567.
    PubMed     Text format     Abstract available


  309. LEDE V, Franke C, Meusel A, Teupser D, et al
    Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor.
    PLoS One. 2016;11:e0167888.
    PubMed     Text format     Abstract available


  310. LANKARANI KB, Malek-Hosseini SA, Nikeghbalian S, Dehghani M, et al
    Fourteen Years of Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases from Shiraz, Iran.
    PLoS One. 2016;11:e0167890.
    PubMed     Text format     Abstract available


  311. IGUCHI T, Nambara S, Masuda T, Komatsu H, et al
    miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver Metastasis.
    PLoS One. 2016;11:e0165912.
    PubMed     Text format     Abstract available


  312. GONZALEZ-PAREDES FJ, Hernandez Mesa G, Morales Arraez D, Marcelino Reyes R, et al
    Contribution of Cyclooxygenase End Products and Oxidative Stress to Intrahepatic Endothelial Dysfunction in Early Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0156650.
    PubMed     Text format     Abstract available


  313. SCHUSTER C, Akslen LA, Straume O
    Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.
    PLoS One. 2016;11:e0155242.
    PubMed     Text format     Abstract available


  314. KIM JC, Ha YJ, Tak KH, Roh SA, et al
    Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer.
    PLoS One. 2016;11:e0155160.
    PubMed     Text format     Abstract available


  315. SHANAKI M, Fadaei R, Moradi N, Emamgholipour S, et al
    The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients.
    PLoS One. 2016;11:e0168082.
    PubMed     Text format     Abstract available


  316. ZHOU Z, Song K, Qiu J, Wang Y, et al
    Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males.
    PLoS One. 2016;11:e0166072.
    PubMed     Text format     Abstract available


  317. WU S, Wang YJ, Tang X, Wang Y, et al
    Genetic Polymorphisms of Glutathione S-Transferase P1 (GSTP1) and the Incidence of Anti-Tuberculosis Drug-Induced Hepatotoxicity.
    PLoS One. 2016;11:e0157478.
    PubMed     Text format     Abstract available


  318. VESPASIANI-GENTILUCCI U, Gallo P, Piemonte F, Riva E, et al
    Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology.
    PLoS One. 2016;11:e0156113.
    PubMed     Text format     Abstract available


  319. GADALEAN F, Lighezan D, Stoian D, Schiller O, et al
    The Survival of Roma Minority Patients on Chronic Hemodialysis Therapy - A Romanian Multicenter Survey.
    PLoS One. 2016;11:e0155271.
    PubMed     Text format     Abstract available


  320. FIX OK, Liou I, Karvellas CJ, Ganger DR, et al
    Development and Pilot of a Checklist for Management of Acute Liver Failure in the Intensive Care Unit.
    PLoS One. 2016;11:e0155500.
    PubMed     Text format     Abstract available


  321. TISCHENDORF M, Miesbach W, Chattah U, Chattah Z, et al
    Differential Kinetics of Coagulation Factors and Natural Anticoagulants in Patients with Liver Cirrhosis: Potential Clinical Implications.
    PLoS One. 2016;11:e0155337.
    PubMed     Text format     Abstract available


  322. APRELIKOVA O, Tomlinson CC, Hoenerhoff M, Hixon JA, et al
    Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
    PLoS One. 2016;11:e0155262.
    PubMed     Text format     Abstract available


  323. OKAMOTO K, Koda M, Okamoto T, Onoyama T, et al
    A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.
    PLoS One. 2016;11:e0154676.
    PubMed     Text format     Abstract available


  324. JEURISSEN ML, Walenbergh SM, Houben T, Hendrikx T, et al
    Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice.
    PLoS One. 2016;11:e0167199.
    PubMed     Text format     Abstract available


  325. DELEURAN T, Vilstrup H, Overgaard S, Jepsen P, et al
    No Increased Risk for Primary Osteoarthritis in Liver Cirrhosis - A Danish Nationwide Cohort Study.
    PLoS One. 2016;11:e0167134.
    PubMed     Text format     Abstract available


  326. PARK SD, Moon J, Kwon SW, Suh YJ, et al
    Prognostic Impact of Combined Contrast-Induced Acute Kidney Injury and Hypoxic Liver Injury in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results from INTERSTELLAR Registry.
    PLoS One. 2016;11:e0159416.
    PubMed     Text format     Abstract available


  327. MARIN V, Rosso N, Dal Ben M, Raseni A, et al
    An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
    PLoS One. 2016;11:e0158817.
    PubMed     Text format     Abstract available


  328. LAHMER T, Brandl A, Rasch S, Schmid RM, et al
    Fungal Peritonitis: Underestimated Disease in Critically Ill Patients with Liver Cirrhosis and Spontaneous Peritonitis.
    PLoS One. 2016;11:e0158389.
    PubMed     Text format     Abstract available


  329. SI WK, Chung JW, Cho J, Baeg JY, et al
    Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes.
    PLoS One. 2016;11:e0158066.
    PubMed     Text format     Abstract available


  330. GAVITO AL, Bautista D, Suarez J, Badran S, et al
    Chronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese Mice.
    PLoS One. 2016;11:e0157956.
    PubMed     Text format     Abstract available


  331. ARAUJO-MARIZ C, Lopes EP, Acioli-Santos B, Maruza M, et al
    Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS.
    PLoS One. 2016;11:e0157725.
    PubMed     Text format     Abstract available


  332. JURADO-GARCIA J, Munoz Garcia-Borruel M, Rodriguez-Peralvarez ML, Ruiz-Cuesta P, et al
    Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality.
    PLoS One. 2016;11:e0155822.
    PubMed     Text format     Abstract available


  333. WANG D, Lin H, Xia M, Aleteng Q, et al
    Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng Study.
    PLoS One. 2016;11:e0157515.
    PubMed     Text format     Abstract available


  334. LEE KF, Tsai YT, Lin CY, Hsieh CB, et al
    Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan.
    PLoS One. 2016;11:e0155602.
    PubMed     Text format     Abstract available


  335. XIA MF, Yki-Jarvinen H, Bian H, Lin HD, et al
    Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0160526.
    PubMed     Text format     Abstract available


  336. ZHANG C, Yuan W, Fang J, Wang W, et al
    Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials.
    PLoS One. 2016;11:e0161792.
    PubMed     Text format     Abstract available


  337. GADDAM RR, Fraser R, Badiei A, Chambers S, et al
    Cystathionine-Gamma-Lyase Gene Deletion Protects Mice against Inflammation and Liver Sieve Injury following Polymicrobial Sepsis.
    PLoS One. 2016;11:e0160521.
    PubMed     Text format     Abstract available


  338. GRAUPERA I, Sola E, Fabrellas N, Moreira R, et al
    Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.
    PLoS One. 2016;11:e0157371.
    PubMed     Text format     Abstract available


  339. HU S, Zou Z, Li H, Zou G, et al
    The Preoperative Peripheral Blood Monocyte Count Is Associated with Liver Metastasis and Overall Survival in Colorectal Cancer Patients.
    PLoS One. 2016;11:e0157486.
    PubMed     Text format     Abstract available


  340. SUZUKI-KEMURIYAMA N, Matsuzaka T, Kuba M, Ohno H, et al
    Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
    PLoS One. 2016;11:e0157580.
    PubMed     Text format     Abstract available


  341. HUNG TH, Lay CJ, Tseng CW, Tsai CC, et al
    The Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients: A Nationwide Population-Based 3-Year Follow-up Study.
    PLoS One. 2016;11:e0162987.
    PubMed     Text format     Abstract available


  342. KLEIN S, Hinuber C, Hittatiya K, Schierwagen R, et al
    Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension.
    PLoS One. 2016;11:e0162144.
    PubMed     Text format     Abstract available


  343. HASEGAWA K, Saiura A, Takayama T, Miyagawa S, et al
    Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
    PLoS One. 2016;11:e0162400.
    PubMed     Text format     Abstract available


  344. RACHAKONDA V, Borhani AA, Dunn MA, Andrzejewski M, et al
    Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis.
    PLoS One. 2016;11:e0159142.
    PubMed     Text format     Abstract available


  345. SANSOE G, Aragno M, Mastrocola R, Mengozzi G, et al
    Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data.
    PLoS One. 2016;11:e0162644.
    PubMed     Text format     Abstract available


  346. LIU Y, Zhang S, Zhao Y, Du J, et al
    Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B.
    PLoS One. 2016;11:e0162763.
    PubMed     Text format     Abstract available


  347. CHANG M, Tang H, Liu D, Li Y, et al
    Comparison of Melatonin, Hypertonic Saline, and Hydroxyethyl Starch for Resuscitation of Secondary Intra-Abdominal Hypertension in an Animal Model.
    PLoS One. 2016;11:e0161688.
    PubMed     Text format     Abstract available


  348. PELUSI S, Petta S, Rosso C, Borroni V, et al
    Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0163069.
    PubMed     Text format     Abstract available


    January 2015
  349. HONG M, Kim SW, Han SH, Kim DJ, et al
    Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) Reduce the Expression of Toll-Like Receptor 4 in Mice with Alcoholic Liver Disease.
    PLoS One. 2015;10:e0117451.
    PubMed     Text format     Abstract available


  350. GOMEZ-ANSON B, Roman E, Fernandez de Bobadilla R, Pires-Encuentra P, et al
    Alterations in cerebral white matter and neuropsychology in patients with cirrhosis and falls.
    PLoS One. 2015;10:e0118930.
    PubMed     Text format     Abstract available


  351. MENG Y, Liang Y, Liu M
    The value of MRI in the diagnosis of primary biliary cirrhosis and assessment of liver fibrosis.
    PLoS One. 2015;10:e0120110.
    PubMed     Text format     Abstract available


  352. CHEN G, Lu L, Liu C, Shan L, et al
    MicroRNA-377 suppresses cell proliferation and invasion by inhibiting TIAM1 expression in hepatocellular carcinoma.
    PLoS One. 2015;10:e0117714.
    PubMed     Text format     Abstract available


  353. HSU CY, Liu PH, Lee YH, Hsia CY, et al
    Using serum alpha-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff?
    PLoS One. 2015;10:e0118825.
    PubMed     Text format     Abstract available


  354. LI J, Chanrion M, Sawey E, Wang T, et al
    Reciprocal interaction of Wnt and RXR-alpha pathways in hepatocyte development and hepatocellular carcinoma.
    PLoS One. 2015;10:e0118480.
    PubMed     Text format     Abstract available


  355. HASHIZUME O, Yamanashi H, Taketo MM, Nakada K, et al
    A Specific Nuclear DNA Background Is Required for High Frequency Lymphoma Development in Transmitochondrial Mice with G13997A mtDNA.
    PLoS One. 2015;10:e0118561.
    PubMed     Text format     Abstract available


  356. LIM YP, Lin CL, Lin YN, Ma WC, et al
    Antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts.
    PLoS One. 2015;10:e0116960.
    PubMed     Text format     Abstract available


  357. HEIJMEN L, Ter Voert EE, Oyen WJ, Punt CJ, et al
    Multimodality Imaging to Predict Response to Systemic Treatment in Patients with Advanced Colorectal Cancer.
    PLoS One. 2015;10:e0120823.
    PubMed     Text format     Abstract available


  358. ANG SF, Ng ES, Li H, Ong YH, et al
    The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.
    PLoS One. 2015;10:e0118658.
    PubMed     Text format     Abstract available


  359. ZHANG T, Kho DH, Wang Y, Harazono Y, et al
    Gp78, an E3 ubiquitin ligase acts as a gatekeeper suppressing nonalcoholic steatohepatitis (NASH) and liver cancer.
    PLoS One. 2015;10:e0118448.
    PubMed     Text format     Abstract available


  360. WU JR, Hu CT, You RI, Ma PL, et al
    Preclinical trials for prevention of tumor progression of hepatocellular carcinoma by LZ-8 targeting c-Met dependent and independent pathways.
    PLoS One. 2015;10:e0114495.
    PubMed     Text format     Abstract available


  361. HOFFMANN CJ, Hoffmann JD, Kensler C, van der Watt M, et al
    Tuberculosis and Hepatic Steatosis Are Prevalent Liver Pathology Findings among HIV-Infected Patients in South Africa.
    PLoS One. 2015;10:e0117813.
    PubMed     Text format     Abstract available


  362. CAO L, Tong H, Xu G, Liu P, et al
    Systemic lupus erythematous and malignancy risk: a meta-analysis.
    PLoS One. 2015;10:e0122964.
    PubMed     Text format     Abstract available


  363. SPEISER JL, Lee WM, Karvellas CJ
    Predicting outcome on admission and post-admission for acetaminophen-induced acute liver failure using classification and regression tree models.
    PLoS One. 2015;10:e0122929.
    PubMed     Text format     Abstract available


  364. JING Y, Wu K, Liu J, Ai Q, et al
    Aminotriazole Alleviates Acetaminophen Poisoning via Downregulating P450 2E1 and Suppressing Inflammation.
    PLoS One. 2015;10:e0122781.
    PubMed     Text format     Abstract available


  365. LIN YY, Shiau S, Fang CT
    Risk Factors for Invasive Cryptococcus neoformans Diseases: A Case-Control Study.
    PLoS One. 2015;10:e0119090.
    PubMed     Text format     Abstract available


  366. WU YC, Lo HY, Yang SL, Chu DC, et al
    Comparing the Factors Correlated with Tuberculosis-Specific and Non-Tuberculosis-Specific Deaths in Different Age Groups among Tuberculosis-Related Deaths in Taiwan.
    PLoS One. 2015;10:e0118929.
    PubMed     Text format     Abstract available


  367. PARK M, Chung YE, Kim KA, Chung WS, et al
    Added value of arterial enhancement fraction color maps for the characterization of small hepatic low-attenuating lesions in patients with colorectal cancer.
    PLoS One. 2015;10:e0114819.
    PubMed     Text format     Abstract available


  368. HU H, Duan Z, Long X, Hertzanu Y, et al
    Comparison of treatment safety and patient survival in elderly versus nonelderly patients with advanced hepatocellular carcinoma receiving sorafenib combined with transarterial chemoembolization: a propensity score matching study.
    PLoS One. 2015;10:e0117168.
    PubMed     Text format     Abstract available


  369. ZHANG L, Song H, Ge Y, Ji G, et al
    Temporal relationship between diet-induced steatosis and onset of insulin/leptin resistance in male Wistar rats.
    PLoS One. 2015;10:e0117008.
    PubMed     Text format     Abstract available


  370. RING M, Eskofier BM
    Data mining in the U.S. National Toxicology Program (NTP) database reveals a potential bias regarding liver tumors in rodents irrespective of the test agent.
    PLoS One. 2015;10:e0116488.
    PubMed     Text format     Abstract available


  371. DONGIOVANNI P, Lanti C, Gatti S, Rametta R, et al
    High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload.
    PLoS One. 2015;10:e0116855.
    PubMed     Text format     Abstract available


  372. KOEPKE J, Dresel M, Schmid S, Greulich T, et al
    Therapy with plasma purified alpha1-antitrypsin (Prolastin(R)) induces time-dependent changes in plasma levels of MMP-9 and MPO.
    PLoS One. 2015;10:e0117497.
    PubMed     Text format     Abstract available


  373. JIANG L, Zhang Q, Ren H, Ma S, et al
    Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells.
    PLoS One. 2015;10:e0124994.
    PubMed     Text format     Abstract available


  374. LI LY, Yang WM, Chen HZ, Wu YH, et al
    Successful Splenectomy for Hypersplenism in Wilson's Disease: A Single Center Experience from China.
    PLoS One. 2015;10:e0124569.
    PubMed     Text format     Abstract available


  375. DECARIS ML, Emson CL, Li K, Gatmaitan M, et al
    Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.
    PLoS One. 2015;10:e0123311.
    PubMed     Text format     Abstract available


  376. ZHU X, Wu L, Yao J, Jiang H, et al
    MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0124266.
    PubMed     Text format     Abstract available


  377. DONG H, Zhang L, Qian Z, Zhu X, et al
    Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0123175.
    PubMed     Text format     Abstract available


  378. ZHE C, Yu F, Tian J, Zheng S, et al
    Trps1 regulates biliary epithelial-mesenchymal transition and has roles during biliary fibrosis in liver grafts: a preliminary study.
    PLoS One. 2015;10:e0123233.
    PubMed     Text format     Abstract available


  379. AHRONIAN LG, Driscoll DR, Klimstra DS, Lewis BC, et al
    The p53R172H mutant does not enhance hepatocellular carcinoma development and progression.
    PLoS One. 2015;10:e0123816.
    PubMed     Text format     Abstract available


  380. RAYMOND AA, Benhamouche S, Neaud V, Di Martino J, et al
    Reptin regulates DNA double strand breaks repair in human hepatocellular carcinoma.
    PLoS One. 2015;10:e0123333.
    PubMed     Text format     Abstract available


  381. GAO M, Ma Y, Liu D
    High-Fat Diet-Induced Adiposity, Adipose Inflammation, Hepatic Steatosis and Hyperinsulinemia in Outbred CD-1 Mice.
    PLoS One. 2015;10:e0119784.
    PubMed     Text format     Abstract available


  382. TAN C, Liu S, Tan S, Zeng X, et al
    Polymorphisms in microRNA target sites of forkhead box O genes are associated with hepatocellular carcinoma.
    PLoS One. 2015;10:e0119210.
    PubMed     Text format     Abstract available


  383. SUMI A, Akiba J, Ogasawara S, Nakayama M, et al
    Des-gamma-carboxyprothrombin (DCP) and NX-DCP expressions and their relationship with clinicopathological features in hepatocellular carcinoma.
    PLoS One. 2015;10:e0118452.
    PubMed     Text format     Abstract available


  384. HUANG WJ, Jeng YM, Lai HS, Fong IU, et al
    Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
    PLoS One. 2015;10:e0119181.
    PubMed     Text format     Abstract available


  385. LI W, Yu J, Lian B, Sun H, et al
    Identifying prognostic features by bottom-up approach and correlating to drug repositioning.
    PLoS One. 2015;10:e0118672.
    PubMed     Text format     Abstract available


  386. FANG Z, Zhou L, Jiang S, Cao L, et al
    UNC50 prompts G1/S transition and proliferation in HCC by regulation of epidermal growth factor receptor trafficking.
    PLoS One. 2015;10:e0119338.
    PubMed     Text format     Abstract available


  387. HOCHST B, Mikulec J, Baccega T, Metzger C, et al
    Differential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosis.
    PLoS One. 2015;10:e0119662.
    PubMed     Text format     Abstract available


  388. DUPRE A, Melodelima D, Perol D, Chen Y, et al
    First clinical experience of intra-operative high intensity focused ultrasound in patients with colorectal liver metastases: a phase I-IIa study.
    PLoS One. 2015;10:e0118212.
    PubMed     Text format     Abstract available


  389. BUSBEE PB, Nagarkatti M, Nagarkatti PS
    Natural Indoles, Indole-3-Carbinol (I3C) and 3,3'-Diindolylmethane (DIM), Attenuate Staphylococcal Enterotoxin B-Mediated Liver Injury by Downregulating miR-31 Expression and Promoting Caspase-2-Mediated Apoptosis.
    PLoS One. 2015;10:e0118506.
    PubMed     Text format     Abstract available


  390. POURHOSEINI S, Seth RK, Das S, Dattaroy D, et al
    Upregulation of miR21 and repression of Grhl3 by leptin mediates sinusoidal endothelial injury in experimental nonalcoholic steatohepatitis.
    PLoS One. 2015;10:e0116780.
    PubMed     Text format     Abstract available


  391. TSAI HC, Lin YC, Ko CL, Lou HY, et al
    Propofol versus Midazolam for Upper Gastrointestinal Endoscopy in Cirrhotic Patients: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2015;10:e0117585.
    PubMed     Text format     Abstract available


  392. KENERSON HL, Subramanian S, McIntyre R, Kazami M, et al
    Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt.
    PLoS One. 2015;10:e0117000.
    PubMed     Text format     Abstract available


  393. TUNG HC, Lee FY, Wang SS, Tsai MH, et al
    The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis.
    PLoS One. 2015;10:e0124654.
    PubMed     Text format     Abstract available


  394. HATZIAGELAKI E, Herder C, Tsiavou A, Teichert T, et al
    Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD).
    PLoS One. 2015;10:e0124935.
    PubMed     Text format     Abstract available


  395. YANG J, Li X, Yang R, Yu X, et al
    Susceptibility-Weighted Imaging Manifestations in the Brain of Wilson's Disease Patients.
    PLoS One. 2015;10:e0125100.
    PubMed     Text format     Abstract available


  396. WAN S, Wu Y, Zhou X, Chen Y, et al
    Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0124471.
    PubMed     Text format     Abstract available


  397. DE NIZ M, Helm S, Horstmann S, Annoura T, et al
    In vivo and in vitro characterization of a Plasmodium liver stage-specific promoter.
    PLoS One. 2015;10:e0123473.
    PubMed     Text format     Abstract available


  398. SHABANI P, Naeimi Khaledi H, Beigy M, Emamgholipour S, et al
    Circulating level of CTRP1 in patients with nonalcoholic fatty liver disease (NAFLD): is it through insulin resistance?
    PLoS One. 2015;10:e0118650.
    PubMed     Text format     Abstract available


  399. FAN W, Zhang Y, Wang Y, Yao X, et al
    Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization.
    PLoS One. 2015;10:e0119312.
    PubMed     Text format     Abstract available


  400. TIVERS MS, Handel I, Gow AG, Lipscomb VJ, et al
    Attenuation of congenital portosystemic shunt reduces inflammation in dogs.
    PLoS One. 2015;10:e0117557.
    PubMed     Text format     Abstract available


  401. CHA YL, Li PD, Yuan LJ, Zhang MY, et al
    EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma.
    PLoS One. 2015;10:e0117493.
    PubMed     Text format     Abstract available


  402. ANOTA A, Mouillet G, Trouilloud I, Dupont-Gossart AC, et al
    Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.
    PLoS One. 2015;10:e0125350.
    PubMed     Text format     Abstract available


  403. GUO Z, Zhang J, Jiang JH, Li LQ, et al
    Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy.
    PLoS One. 2015;10:e0125649.
    PubMed     Text format     Abstract available


  404. PARENTE DB, Paiva FF, Oliveira Neto JA, Machado-Silva L, et al
    Intravoxel Incoherent Motion Diffusion Weighted MR Imaging at 3.0 T: Assessment of Steatohepatitis and Fibrosis Compared with Liver Biopsy in Type 2 Diabetic Patients.
    PLoS One. 2015;10:e0125653.
    PubMed     Text format     Abstract available


  405. KURT R, Chandra PK, Aboulnasr F, Panigrahi R, et al
    Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
    PLoS One. 2015;10:e0125962.
    PubMed     Text format     Abstract available


  406. BERTHELIER V, Harris JB, Estenson KN, Baudry J, et al
    Discovery of an inhibitor of Z-alpha1 antitrypsin polymerization.
    PLoS One. 2015;10:e0126256.
    PubMed     Text format     Abstract available


  407. MARCAN M, Kos B, Miklavcic D
    Effect of blood vessel segmentation on the outcome of electroporation-based treatments of liver tumors.
    PLoS One. 2015;10:e0125591.
    PubMed     Text format     Abstract available


  408. XU J, Teng IT, Zhang L, Delgado S, et al
    Molecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated via Cell-SELEX.
    PLoS One. 2015;10:e0125863.
    PubMed     Text format     Abstract available


  409. AKIE TE, Liu L, Nam M, Lei S, et al
    OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2015;10:e0125617.
    PubMed     Text format     Abstract available


  410. YANG BL, Wu WC, Fang KC, Wang YC, et al
    External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan.
    PLoS One. 2015;10:e0120443.
    PubMed     Text format     Abstract available


  411. CHEN YL, Lin HC, Lin KH, Lin LS, et al
    Low hemoglobin level is associated with the development of delirium after hepatectomy for hepatocellular carcinoma patients.
    PLoS One. 2015;10:e0119199.
    PubMed     Text format     Abstract available


  412. LOUREIRO CL, Aguilar JC, Aguiar J, Muzio V, et al
    HBV genotypic variability in Cuba.
    PLoS One. 2015;10:e0118959.
    PubMed     Text format     Abstract available


  413. CHEN Z, Zhu J, Huang C, Lian F, et al
    The association between three cyclooxygenase-2 polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
    PLoS One. 2015;10:e0118251.
    PubMed     Text format     Abstract available


  414. CHEN J, Wu M, Liu R, Li S, et al
    Preoperative evaluation of the histological grade of hepatocellular carcinoma with diffusion-weighted imaging: a meta-analysis.
    PLoS One. 2015;10:e0117661.
    PubMed     Text format     Abstract available


  415. D'ARCANGELO M, Todaro M, Salvini J, Benfante A, et al
    Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study.
    PLoS One. 2015;10:e0125037.
    PubMed     Text format     Abstract available


  416. KNABEL MK, Ramachandran K, Karhadkar S, Hwang HW, et al
    Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice.
    PLoS One. 2015;10:e0124411.
    PubMed     Text format     Abstract available


  417. BOGAERTS E, Heindryckx F, Devisscher L, Paridaens A, et al
    Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors.
    PLoS One. 2015;10:e0119555.
    PubMed     Text format     Abstract available


  418. FRADES I, Andreasson E, Mato JM, Alexandersson E, et al
    Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic Fatty liver disease.
    PLoS One. 2015;10:e0124544.
    PubMed     Text format     Abstract available


  419. MOELLER M, Thonig A, Pohl S, Ripoll C, et al
    Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis.
    PLoS One. 2015;10:e0121229.
    PubMed     Text format     Abstract available


  420. SCHWEIGER T, Nikolowsky C, Starlinger P, Traxler D, et al
    Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases.
    PLoS One. 2015;10:e0120724.
    PubMed     Text format     Abstract available


  421. ZHANG Q, Li Y, Han T, Nie C, et al
    Comparison of current diagnostic criteria for acute-on-chronic liver failure.
    PLoS One. 2015;10:e0122158.
    PubMed     Text format     Abstract available


  422. RIGALLI JP, Ciriaci N, Arias A, Ceballos MP, et al
    Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicity.
    PLoS One. 2015;10:e0119502.
    PubMed     Text format     Abstract available


  423. FENG D, Youn DY, Zhao X, Gao Y, et al
    mTORC1 Down-Regulates Cyclin-Dependent Kinase 8 (CDK8) and Cyclin C (CycC).
    PLoS One. 2015;10:e0126240.
    PubMed     Text format     Abstract available


  424. IMAI N, Suzuki M, Hayashi K, Ishigami M, et al
    Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat Diet.
    PLoS One. 2015;10:e0127114.
    PubMed     Text format     Abstract available


  425. KIM SH, Wu SY, Baek JI, Choi SY, et al
    A post-developmental genetic screen for zebrafish models of inherited liver disease.
    PLoS One. 2015;10:e0125980.
    PubMed     Text format     Abstract available


  426. JANG JW, Kim YW, Lee SW, Kwon JH, et al
    Reactivation of Hepatitis B Virus in HBsAg-Negative Patients with Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0122041.
    PubMed     Text format     Abstract available


  427. CHOI JE, Kwon JH, Kim JH, Hur W, et al
    Suppression of dual specificity phosphatase I expression inhibits hepatitis C virus replication.
    PLoS One. 2015;10:e0119172.
    PubMed     Text format     Abstract available


  428. OGATA Y, Matono K, Tsuda H, Ushijima M, et al
    Randomized Phase II Study of 5-Fluorouracil Hepatic Arterial Infusion with or without Antineoplastons as an Adjuvant Therapy after Hepatectomy for Liver Metastases from Colorectal Cancer.
    PLoS One. 2015;10:e0120064.
    PubMed     Text format     Abstract available


  429. JHARAP B, van Asseldonk DP, de Boer NK, Bedossa P, et al
    Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement.
    PLoS One. 2015;10:e0120299.
    PubMed     Text format     Abstract available


  430. LU L, Zhou J, Shi J, Peng XJ, et al
    Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients.
    PLoS One. 2015;10:e0127524.
    PubMed     Text format     Abstract available


  431. MERLI M, Lucidi C, Di Gregorio V, Falcone M, et al
    The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.
    PLoS One. 2015;10:e0127448.
    PubMed     Text format     Abstract available


  432. LIN WC, Hsu TW, Chen CL, Lu CH, et al
    Resting State-fMRI with ReHo Analysis as a Non-Invasive Modality for the Prognosis of Cirrhotic Patients with Overt Hepatic Encephalopathy.
    PLoS One. 2015;10:e0126834.
    PubMed     Text format     Abstract available


  433. ZAKRZEWSKA KE, Samluk A, Wierzbicki M, Jaworski S, et al
    Analysis of the cytotoxicity of carbon-based nanoparticles, diamond and graphite, in human glioblastoma and hepatoma cell lines.
    PLoS One. 2015;10:e0122579.
    PubMed     Text format     Abstract available


  434. MARTEL G, Hawel J, Rekman J, Croome KP, et al
    Liver resection for non-colorectal, non-carcinoid, non-sarcoma metastases: a multicenter study.
    PLoS One. 2015;10:e0120569.
    PubMed     Text format     Abstract available


  435. CHANG CH, Chen YC, Zhang W, Leung PS, et al
    Innate immunity drives the initiation of a murine model of primary biliary cirrhosis.
    PLoS One. 2015;10:e0121320.
    PubMed     Text format     Abstract available


  436. LIN X, Jia J, Du T, Li W, et al
    Overexpression of miR-155 in the liver of transgenic mice alters the expression profiling of hepatic genes associated with lipid metabolism.
    PLoS One. 2015;10:e0118417.
    PubMed     Text format     Abstract available


  437. HE L, Gao L, Shi Z, Li Y, et al
    Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case-Control Study.
    PLoS One. 2015;10:e0119481.
    PubMed     Text format     Abstract available


  438. CAI L, Cai MH, Wang MY, Xu YF, et al
    Meta-Analysis-Based Preliminary Exploration of the Connection between ATDILI and Schizophrenia by GSTM1/T1 Gene Polymorphisms.
    PLoS One. 2015;10:e0128643.
    PubMed     Text format     Abstract available


  439. ZHANG J, Chong CC, Chen GG, Lai PB, et al
    A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0128628.
    PubMed     Text format     Abstract available


  440. NEZAMI RANJBAR MR, Luo Y, Di Poto C, Varghese RS, et al
    GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort.
    PLoS One. 2015;10:e0127299.
    PubMed     Text format     Abstract available


  441. LI J, Hernanda PY, Bramer WM, Peppelenbosch MP, et al
    Anti-tumor effects of metformin in animal models of hepatocellular carcinoma: a systematic review and meta-analysis.
    PLoS One. 2015;10:e0127967.
    PubMed     Text format     Abstract available


  442. LIN CM, Huang HL, Chu FY, Fan HC, et al
    Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study.
    PLoS One. 2015;10:e0125421.
    PubMed     Text format     Abstract available


  443. JIN P, Chen Y, Lv L, Yang J, et al
    Lactobacillus fermentum ZYL0401 Attenuates Lipopolysaccharide-Induced Hepatic TNF-alpha Expression and Liver Injury via an IL-10- and PGE2-EP4-Dependent Mechanism.
    PLoS One. 2015;10:e0126520.
    PubMed     Text format     Abstract available


  444. LIANG T, Alloosh M, Bell LN, Fullenkamp A, et al
    Liver injury and fibrosis induced by dietary challenge in the Ossabaw miniature Swine.
    PLoS One. 2015;10:e0124173.
    PubMed     Text format     Abstract available


  445. CHIU KW, Nakano T, Chen KD, Hsu LW, et al
    Repeated-measures implication of hepatocellular carcinoma biomarkers in living donor liver transplantation.
    PLoS One. 2015;10:e0124943.
    PubMed     Text format     Abstract available


  446. BEIER JI, Jokinen JD, Holz GE, Whang PS, et al
    Novel mechanism of arenavirus-induced liver pathology.
    PLoS One. 2015;10:e0122839.
    PubMed     Text format     Abstract available


  447. KONUMA K, Itoh M, Suganami T, Kanai S, et al
    Eicosapentaenoic Acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient mice.
    PLoS One. 2015;10:e0121528.
    PubMed     Text format     Abstract available


  448. SCOTT C, Cha K, Rao R, Liddle C, et al
    Hepatocyte-specific deletion of ARNT (aryl hydrocarbon Receptor Nuclear Translocator) results in altered fibrotic gene expression in the thioacetamide model of liver injury.
    PLoS One. 2015;10:e0121650.
    PubMed     Text format     Abstract available


  449. EL-SAYED YS, Lebda MA, Hassinin M, Neoman SA, et al
    Chicory (Cichorium intybus L.) root extract regulates the oxidative status and antioxidant gene transcripts in CCl4-induced hepatotoxicity.
    PLoS One. 2015;10:e0121549.
    PubMed     Text format     Abstract available


  450. SEBASTIANI G, Alshaalan R, Wong P, Rubino M, et al
    Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis.
    PLoS One. 2015;10:e0128774.
    PubMed     Text format     Abstract available


  451. ALTEKRUSE SF, Petrick JL, Rolin AI, Cuccinelli JE, et al
    Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.
    PLoS One. 2015;10:e0120574.
    PubMed     Text format     Abstract available


  452. KAYSER BD, Goran MI, Bouret SG
    Perinatal overnutrition exacerbates adipose tissue inflammation caused by high-fat feeding in C57BL/6J mice.
    PLoS One. 2015;10:e0121954.
    PubMed     Text format     Abstract available


  453. CAI ZQ, Si SB, Chen C, Zhao Y, et al
    Analysis of prognostic factors for survival after hepatectomy for hepatocellular carcinoma based on a bayesian network.
    PLoS One. 2015;10:e0120805.
    PubMed     Text format     Abstract available


  454. LIU YY, Li CP, Huai MS, Fu XM, et al
    Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.
    PLoS One. 2015;10:e0120939.
    PubMed     Text format     Abstract available


  455. KIM HM, Lee ES, Lee BR, Yadav D, et al
    C-C Chemokine Receptor 2 Inhibitor Ameliorates Hepatic Steatosis by Improving ER Stress and Inflammation in a Type 2 Diabetic Mouse Model.
    PLoS One. 2015;10:e0120711.
    PubMed     Text format     Abstract available


  456. SONG B, Bian Q, Shao CH, Li G, et al
    Ulinastatin reduces the resistance of liver cancer cells to epirubicin by inhibiting autophagy.
    PLoS One. 2015;10:e0120694.
    PubMed     Text format     Abstract available


  457. STRICK-MARCHAND H, Dusseaux M, Darche S, Huntington ND, et al
    A novel mouse model for stable engraftment of a human immune system and human hepatocytes.
    PLoS One. 2015;10:e0119820.
    PubMed     Text format     Abstract available


  458. JAMES MI, Howells LM, Karmokar A, Higgins JA, et al
    Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note.
    PLoS One. 2015;10:e0117776.
    PubMed     Text format     Abstract available


  459. HIRASAWA M, Hagihara K, Okudaira N, Izumi T, et al
    The Possible Mechanism of Idiosyncratic Lapatinib-Induced Liver Injury in Patients Carrying Human Leukocyte Antigen-DRB1*07:01.
    PLoS One. 2015;10:e0130928.
    PubMed     Text format     Abstract available


  460. HU Z, Wan X, Hao R, Zhang H, et al
    Phosphorylation of mutationally introduced tyrosine in the activation loop of HER2 confers gain-of-function activity.
    PLoS One. 2015;10:e0123623.
    PubMed     Text format     Abstract available


  461. WHITE SB, Chen J, Gordon AC, Harris KR, et al
    Percutaneous ultrasound guided implantation of VX2 for creation of a rabbit hepatic tumor model.
    PLoS One. 2015;10:e0123888.
    PubMed     Text format     Abstract available


  462. PARK Y, Kim SU, Park SY, Kim BK, et al
    A novel model to predict esophageal varices in patients with compensated cirrhosis using acoustic radiation force impulse elastography.
    PLoS One. 2015;10:e0121009.
    PubMed     Text format     Abstract available


  463. JEONG WK, Kim TY, Sohn JH, Kim Y, et al
    Severe portal hypertension in cirrhosis: evaluation of perfusion parameters with contrast-enhanced ultrasonography.
    PLoS One. 2015;10:e0121601.
    PubMed     Text format     Abstract available


  464. YANG M, Xu D, Liu Y, Guo X, et al
    Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis.
    PLoS One. 2015;10:e0131664.
    PubMed     Text format     Abstract available


  465. KASZTELAN-SZCZERBINSKA B, Surdacka A, Celinski K, Rolinski J, et al
    Prognostic Significance of the Systemic Inflammatory and Immune Balance in Alcoholic Liver Disease with a Focus on Gender-Related Differences.
    PLoS One. 2015;10:e0128347.
    PubMed     Text format     Abstract available


  466. SHEU MJ, Hsieh MJ, Chiang WL, Yang SF, et al
    Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.
    PLoS One. 2015;10:e0122961.
    PubMed     Text format     Abstract available


  467. XIA W, Chen W, Zhang Z, Wu D, et al
    Prognostic value, clinicopathologic features and diagnostic accuracy of interleukin-8 in colorectal cancer: a meta-analysis.
    PLoS One. 2015;10:e0123484.
    PubMed     Text format     Abstract available


  468. LIU H, Fu J, Hong R, Liu L, et al
    Acoustic Radiation Force Impulse Elastography for the Non-Invasive Evaluation of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review & Meta-Analysis.
    PLoS One. 2015;10:e0127782.
    PubMed     Text format     Abstract available


  469. TALIB WH, Saleh S
    Propionibacterium acnes Augments Antitumor, Anti-Angiogenesis and Immunomodulatory Effects of Melatonin on Breast Cancer Implanted in Mice.
    PLoS One. 2015;10:e0124384.
    PubMed     Text format     Abstract available


  470. JAGER S, Jacobs S, Kroger J, Stefan N, et al
    Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study.
    PLoS One. 2015;10:e0124749.
    PubMed     Text format     Abstract available


  471. SOARES E SILVA AK, de Oliveira Cipriano Torres D, Dos Santos Gomes FO, Dos Santos Silva B, et al
    LPSF/GQ-02 Inhibits the Development of Hepatic Steatosis and Inflammation in a Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD).
    PLoS One. 2015;10:e0123787.
    PubMed     Text format     Abstract available


  472. LI R, Tang CL, Zhang Y, Ma KS, et al
    Diagnosis of Hepatic Angiomyolipoma by Combination of Baseline and Contrast-Enhanced Ultrasound-A Prospective Study in Non-Cirrhotic Patients.
    PLoS One. 2015;10:e0132290.
    PubMed     Text format     Abstract available


  473. FINKELMEIER F, Kronenberger B, Zeuzem S, Piiper A, et al
    Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis.
    PLoS One. 2015;10:e0132119.
    PubMed     Text format     Abstract available


  474. MEIKLE PJ, Mundra PA, Wong G, Rahman K, et al
    Circulating Lipids Are Associated with Alcoholic Liver Cirrhosis and Represent Potential Biomarkers for Risk Assessment.
    PLoS One. 2015;10:e0130346.
    PubMed     Text format     Abstract available


  475. XING H, Jia K, He J, Shi C, et al
    Establishment of the tree shrew as an alcohol-induced Fatty liver model for the study of alcoholic liver diseases.
    PLoS One. 2015;10:e0128253.
    PubMed     Text format     Abstract available


  476. LIU X, Wang Y, Ming Y, Song Y, et al
    S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis.
    PLoS One. 2015;10:e0127352.
    PubMed     Text format     Abstract available


  477. OHNO T, Shimizu M, Shirakami Y, Baba A, et al
    Metformin Suppresses Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BL/KsJ-+Leprdb/+Leprdb Mice.
    PLoS One. 2015;10:e0124081.
    PubMed     Text format     Abstract available


  478. ZHANG AY, Lai CL, Huang FY, Seto WK, et al
    Evolutionary Changes of Hepatitis B Virus Pre-S Mutations Prior to Development of Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0139478.
    PubMed     Text format     Abstract available


  479. KIMURA T, Takahashi S, Takahashi I, Nishibuchi I, et al
    The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0125231.
    PubMed     Text format     Abstract available


  480. KASUMOV T, Li L, Li M, Gulshan K, et al
    Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.
    PLoS One. 2015;10:e0126910.
    PubMed     Text format     Abstract available


  481. ORNELLAS F, Souza-Mello V, Mandarim-de-Lacerda CA, Aguila MB, et al
    Programming of Obesity and Comorbidities in the Progeny: Lessons from a Model of Diet-Induced Obese Parents.
    PLoS One. 2015;10:e0124737.
    PubMed     Text format     Abstract available


  482. TAKANO Y, Kasai K, Takagishi Y, Kikumori T, et al
    Pancreatic Neuroendocrine Tumors in Mice Deficient in Proglucagon-Derived Peptides.
    PLoS One. 2015;10:e0133812.
    PubMed     Text format     Abstract available


  483. SEKIGUCHI T, Umemura T, Fujimori N, Shibata S, et al
    Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis.
    PLoS One. 2015;10:e0131658.
    PubMed     Text format     Abstract available


  484. SHEN Z, Munker S, Luo F, Ma H, et al
    Effect of Non-Alcoholic Fatty Liver Disease on Estimated Glomerular Filtration Rate Could Be Dependent on Age.
    PLoS One. 2015;10:e0130614.
    PubMed     Text format     Abstract available


  485. CHEN J, Zhang X, Xu Y, Li X, et al
    Hepatic Progenitor Cells Contribute to the Progression of 2-Acetylaminofluorene/Carbon Tetrachloride-Induced Cirrhosis via the Non-Canonical Wnt Pathway.
    PLoS One. 2015;10:e0130310.
    PubMed     Text format     Abstract available


  486. ZHANG W, Shi X, Peng Y, Wu M, et al
    HIF-1alpha Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer.
    PLoS One. 2015;10:e0129603.
    PubMed     Text format     Abstract available


  487. LAPADULA G, Chatenoud L, Gori A, Castelli F, et al
    Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/mul Despite Effective HAART.
    PLoS One. 2015;10:e0124741.
    PubMed     Text format     Abstract available


  488. LIM N, Lidofsky SD
    Impact of Physician Specialty on Quality Care for Patients Hospitalized with Decompensated Cirrhosis.
    PLoS One. 2015;10:e0123490.
    PubMed     Text format     Abstract available


  489. CHEN H, Liu L, Qi X, He C, et al
    Imbalance of Pro- vs. Anti-Coagulation Factors in Chinese Patients with Budd-Chiari Syndrome and Non-Cirrhotic Portal Vein Thrombosis.
    PLoS One. 2015;10:e0119909.
    PubMed     Text format     Abstract available


  490. CAPONE F, Guerriero E, Colonna G, Maio P, et al
    The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 Diabetes.
    PLoS One. 2015;10:e0134594.
    PubMed     Text format     Abstract available


  491. QIN Y, Zhou Y, Chen SH, Zhao XL, et al
    Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.
    PLoS One. 2015;10:e0133496.
    PubMed     Text format     Abstract available


  492. ONIKI K, Saruwatari J, Izuka T, Kajiwara A, et al
    Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.
    PLoS One. 2015;10:e0132640.
    PubMed     Text format     Abstract available


  493. HABKA D, Mann D, Landes R, Soto-Gutierrez A, et al
    Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver Grafts.
    PLoS One. 2015;10:e0131764.
    PubMed     Text format     Abstract available


  494. SODHI K, Puri N, Favero G, Stevens S, et al
    Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.
    PLoS One. 2015;10:e0128648.
    PubMed     Text format     Abstract available


  495. ARIZA X, Sola E, Elia C, Barreto R, et al
    Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis.
    PLoS One. 2015;10:e0128145.
    PubMed     Text format     Abstract available


  496. HSIEH CJ, Wang PW, Hu TH
    Association of Adiponectin Gene Polymorphism with Nonalcoholic Fatty Liver Disease in Taiwanese Patients with Type 2 Diabetes.
    PLoS One. 2015;10:e0127521.
    PubMed     Text format     Abstract available


  497. INAFUKU M, Matsuzaki G, Oku H
    Intravenous Mycobacterium Bovis Bacillus Calmette-Guerin Ameliorates Nonalcoholic Fatty Liver Disease in Obese, Diabetic ob/ob Mice.
    PLoS One. 2015;10:e0128676.
    PubMed     Text format     Abstract available


  498. FLASS T, Tong S, Frank DN, Wagner BD, et al
    Intestinal Lesions Are Associated with Altered Intestinal Microbiome and Are More Frequent in Children and Young Adults with Cystic Fibrosis and Cirrhosis.
    PLoS One. 2015;10:e0116967.
    PubMed     Text format     Abstract available


  499. PARK MH, Shim HS, Kim WH, Kim HJ, et al
    Clinical Risk Scoring Models for Prediction of Acute Kidney Injury after Living Donor Liver Transplantation: A Retrospective Observational Study.
    PLoS One. 2015;10:e0136230.
    PubMed     Text format     Abstract available


  500. LONG X, Chen Q, Zhao J, Rafaels N, et al
    An IL-13 Promoter Polymorphism Associated with Liver Fibrosis in Patients with Schistosoma japonicum.
    PLoS One. 2015;10:e0135360.
    PubMed     Text format     Abstract available


  501. YAN HM, Xia MF, Wang Y, Chang XX, et al
    Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2015;10:e0134172.
    PubMed     Text format     Abstract available


  502. SHIE FS, Shiao YJ, Yeh CW, Lin CH, et al
    Obesity and Hepatic Steatosis Are Associated with Elevated Serum Amyloid Beta in Metabolically Stressed APPswe/PS1dE9 Mice.
    PLoS One. 2015;10:e0134531.
    PubMed     Text format     Abstract available


  503. CHO EJ, Kim MY, Lee JH, Lee IY, et al
    Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis.
    PLoS One. 2015;10:e0133935.
    PubMed     Text format     Abstract available


  504. SANCHEZ-ANTOLIN G, Almohalla-Alvarez C, Bueno P, Almansa R, et al
    Evidence of Active Pro-Fibrotic Response in Blood of Patients with Cirrhosis.
    PLoS One. 2015;10:e0137128.
    PubMed     Text format     Abstract available


  505. HADDAD L, Cassenote AJ, Andraus W, de Martino RB, et al
    Factors Associated with Mortality and Graft Failure in Liver Transplants: A Hierarchical Approach.
    PLoS One. 2015;10:e0134874.
    PubMed     Text format     Abstract available


  506. KLEIN S, Herath CB, Schierwagen R, Grace J, et al
    Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis.
    PLoS One. 2015;10:e0138732.
    PubMed     Text format     Abstract available


  507. LIM EJ, Chin R, Nachbur U, Silke J, et al
    Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
    PLoS One. 2015;10:e0138522.
    PubMed     Text format     Abstract available


  508. KERBERT AJ, Verbeke L, Chiang FW, Laleman W, et al
    Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis.
    PLoS One. 2015;10:e0138264.
    PubMed     Text format     Abstract available


  509. MEI L, Tang Y, Li M, Yang P, et al
    Co-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia obtusifolia L. Ameliorate Non-Alcoholic Fatty Liver.
    PLoS One. 2015;10:e0138078.
    PubMed     Text format     Abstract available


  510. THEYSOHN JM, Ruhlmann M, Muller S, Dechene A, et al
    Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?
    PLoS One. 2015;10:e0137587.
    PubMed     Text format     Abstract available


  511. BEIDERWELLEN K, Geraldo L, Ruhlmann V, Heusch P, et al
    Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases.
    PLoS One. 2015;10:e0137285.
    PubMed     Text format     Abstract available


  512. JUNG YY, Kim HM, Koo JS
    Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.
    PLoS One. 2015;10:e0137204.
    PubMed     Text format     Abstract available


  513. ZHENG S, Lu Q, Xu Y, Wang X, et al
    GdCl3 Attenuates Schistosomiasis japonicum Egg-Induced Granulomatosis Accompanied by Decreased Macrophage Infiltration in Murine Liver.
    PLoS One. 2015;10:e0132222.
    PubMed     Text format     Abstract available


  514. MORRISON MC, Mulder P, Stavro PM, Suarez M, et al
    Replacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined Oil.
    PLoS One. 2015;10:e0139196.
    PubMed     Text format     Abstract available


  515. ZHANG H, Li Y, Hu J, Shen WJ, et al
    Effect of Creosote Bush-Derived NDGA on Expression of Genes Involved in Lipid Metabolism in Liver of High-Fructose Fed Rats: Relevance to NDGA Amelioration of Hypertriglyceridemia and Hepatic Steatosis.
    PLoS One. 2015;10:e0138203.
    PubMed     Text format     Abstract available


  516. GRAMMATIKOS G, Ferreiros N, Waidmann O, Bon D, et al
    Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis.
    PLoS One. 2015;10:e0138130.
    PubMed     Text format     Abstract available


  517. MANTOVANI A, Pernigo M, Bergamini C, Bonapace S, et al
    Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes.
    PLoS One. 2015;10:e0135329.
    PubMed     Text format     Abstract available


  518. CHEN LX, Ning GZ, Zhou ZR, Li YL, et al
    The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies.
    PLoS One. 2015;10:e0123080.
    PubMed     Text format     Abstract available


  519. LIN P, Lu J, Wang Y, Gu W, et al
    Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis.
    PLoS One. 2015;10:e0140346.
    PubMed     Text format     Abstract available


  520. CROOME KP, Lee DD, Burns JM, Perry DK, et al
    Patterns and Outcomes Associated with Patient Migration for Liver Transplantation in the United States.
    PLoS One. 2015;10:e0140295.
    PubMed     Text format     Abstract available


  521. ZHAO L, Xu J, Liang F, Li A, et al
    Effect of Chronic Psychological Stress on Liver Metastasis of Colon Cancer in Mice.
    PLoS One. 2015;10:e0139978.
    PubMed     Text format     Abstract available


  522. CHENG S, Wiklund P, Autio R, Borra R, et al
    Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2015;10:e0138889.
    PubMed     Text format     Abstract available


  523. MOTAWI TK, Shaker OG, El-Maraghy SA, Senousy MA, et al
    Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    PLoS One. 2015;10:e0137706.
    PubMed     Text format     Abstract available


  524. LIU F, Wang X, Wu G, Chen L, et al
    Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis.
    PLoS One. 2015;10:e0142457.
    PubMed     Text format     Abstract available


  525. ANDERSON EL, Howe LD, Jones HE, Higgins JP, et al
    The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0140908.
    PubMed     Text format     Abstract available


  526. FORNARI F, Ferracin M, Trere D, Milazzo M, et al
    Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.
    PLoS One. 2015;10:e0141448.
    PubMed     Text format     Abstract available


  527. MISRA A, Anoop S, Gulati S, Mani K, et al
    Body Fat Patterning, Hepatic Fat and Pancreatic Volume of Non-Obese Asian Indians with Type 2 Diabetes in North India: A Case-Control Study.
    PLoS One. 2015;10:e0140447.
    PubMed     Text format     Abstract available


  528. LEE KS, Kwak Y, Nam KH, Kim DW, et al
    c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer.
    PLoS One. 2015;10:e0139727.
    PubMed     Text format     Abstract available


  529. MA Y, Wang Q, Yang J, Yan L, et al
    Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation.
    PLoS One. 2015;10:e0136604.
    PubMed     Text format     Abstract available


  530. DE OLIVEIRA PR, da Costa CA, de Bem GF, Cordeiro VS, et al
    Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion.
    PLoS One. 2015;10:e0143721.
    PubMed     Text format     Abstract available


  531. HUH JH, Ahn SV, Koh SB, Choi E, et al
    A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study.
    PLoS One. 2015;10:e0143560.
    PubMed     Text format     Abstract available


  532. LI RK, Palmer SL, Zeng MS, Qiang JW, et al
    Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging: Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver.
    PLoS One. 2015;10:e0142882.
    PubMed     Text format     Abstract available


  533. KUMAGAI K, Tabu K, Sasaki F, Takami Y, et al
    Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.
    PLoS One. 2015;10:e0143413.
    PubMed     Text format     Abstract available


  534. BHATT SP, Misra A, Nigam P, Guleria R, et al
    Phenotype, Body Composition, and Prediction Equations (Indian Fatty Liver Index) for Non-Alcoholic Fatty Liver Disease in Non-Diabetic Asian Indians: A Case-Control Study.
    PLoS One. 2015;10:e0142260.
    PubMed     Text format     Abstract available


  535. HE YF, Wang CQ, Yu Y, Qian J, et al
    Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection.
    PLoS One. 2015;10:e0143657.
    PubMed     Text format     Abstract available


  536. WANG ZS, Guo WD, Wu LQ, Yi X, et al
    Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
    PLoS One. 2015;10:e0142727.
    PubMed     Text format     Abstract available


  537. XU C, Qiao Z, Lu Y, Zhang D, et al
    Influence of Fatty Liver on the Severity and Clinical Outcome in Acute Pancreatitis.
    PLoS One. 2015;10:e0142278.
    PubMed     Text format     Abstract available


  538. KARAJAMAKI AJ, Patsi OP, Savolainen M, Kesaniemi YA, et al
    Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).
    PLoS One. 2015;10:e0142937.
    PubMed     Text format     Abstract available


  539. RENGA B, Cipriani S, Carino A, Simonetti M, et al
    Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1.
    PLoS One. 2015;10:e0141082.
    PubMed     Text format     Abstract available


  540. NISHIOJI K, Mochizuki N, Kobayashi M, Kamaguchi M, et al
    The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain >/=10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals.
    PLoS One. 2015;10:e0140427.
    PubMed     Text format     Abstract available


  541. BANERJEE A, Abdelmegeed MA, Jang S, Song BJ, et al
    Increased Sensitivity to Binge Alcohol-Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats.
    PLoS One. 2015;10:e0140498.
    PubMed     Text format     Abstract available


  542. PETTA S, Marrone O, Torres D, Buttacavoli M, et al
    Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2015;10:e0142210.
    PubMed     Text format     Abstract available


  543. KARIMIAN G, Kirschbaum M, Veldhuis ZJ, Bomfati F, et al
    Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice.
    PLoS One. 2015;10:e0143121.
    PubMed     Text format     Abstract available


  544. VONGHIA L, Magrone T, Verrijken A, Michielsen P, et al
    Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features.
    PLoS One. 2015;10:e0143380.
    PubMed     Text format     Abstract available


  545. BERNSMEIER C, Weisskopf DM, Pflueger MO, Mosimann J, et al
    Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls.
    PLoS One. 2015;10:e0143293.
    PubMed     Text format     Abstract available


  546. JIA G, Di F, Wang Q, Shao J, et al
    Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.
    PLoS One. 2015;10:e0142808.
    PubMed     Text format     Abstract available


  547. GRANATA V, Fusco R, Catalano O, Filice S, et al
    Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.
    PLoS One. 2015;10:e0142876.
    PubMed     Text format     Abstract available


  548. BECKER PP, Rau M, Schmitt J, Malsch C, et al
    Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis.
    PLoS One. 2015;10:e0142661.
    PubMed     Text format     Abstract available


  549. JEON JY, Wang HJ, Ock SY, Xu W, et al
    Newly Developed Sarcopenia as a Prognostic Factor for Survival in Patients who Underwent Liver Transplantation.
    PLoS One. 2015;10:e0143966.
    PubMed     Text format     Abstract available


    January 2014
  550. PLELI T, Martin D, Kronenberger B, Brunner F, et al
    Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis - a prospective cohort study.
    PLoS One. 2014;9:e103532.
    PubMed     Text format     Abstract available


  551. SAVERINO D, Pesce G, Antola P, Porcelli B, et al
    High levels of soluble ctla-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis.
    PLoS One. 2014;9:e112509.
    PubMed     Text format     Abstract available


  552. NEGRIN KA, Roth Flach RJ, DiStefano MT, Matevossian A, et al
    IL-1 Signaling in Obesity-Induced Hepatic Lipogenesis and Steatosis.
    PLoS One. 2014;9:e107265.
    PubMed     Text format     Abstract available


  553. LEE YH, Bang H, Park YM, Bae JC, et al
    Non-laboratory-based self-assessment screening score for non-alcoholic Fatty liver disease: development, validation and comparison with other scores.
    PLoS One. 2014;9:e107584.
    PubMed     Text format     Abstract available


  554. LIN WC, Chou KH, Chen CL, Chen HL, et al
    Longitudinal Brain White Matter Alterations in Minimal Hepatic Encephalopathy before and after Liver Transplantation.
    PLoS One. 2014;9:e105887.
    PubMed     Text format     Abstract available


  555. JANSEN C, Eischeid H, Goertzen J, Schierwagen R, et al
    The Role of miRNA-34a as a Prognostic Biomarker for Cirrhotic Patients with Portal Hypertension Receiving TIPS.
    PLoS One. 2014;9:e103779.
    PubMed     Text format     Abstract available


  556. LIU F, Jiao AX, Wu XR, Zhao W, et al
    Impact of glutathione s-transferase m1 and t1 on anti-tuberculosis drug-induced hepatotoxicity in chinese pediatric patients.
    PLoS One. 2014;9:e115410.
    PubMed     Text format     Abstract available


  557. GORCZYNSKI RM, Chen Z, Erin N, Khatri I, et al
    Comparison of Immunity in Mice Cured of Primary/Metastatic Growth of EMT6 or 4THM Breast Cancer by Chemotherapy or Immunotherapy.
    PLoS One. 2014;9:e113597.
    PubMed     Text format     Abstract available


  558. TAN Y, Pan T, Ye Y, Ge G, et al
    Serum MicroRNAs as Potential Biomarkers of Primary Biliary Cirrhosis.
    PLoS One. 2014;9:e111424.
    PubMed     Text format     Abstract available


  559. ZHU X, Zhang J, Fan W, Gong Y, et al
    MAPKAP1 rs10118570 Polymorphism Is Associated with Anti-Infection and Anti-Hepatic Fibrogenesis in Schistosomiasis Japonica.
    PLoS One. 2014;9:e105995.
    PubMed     Text format     Abstract available


  560. CHEN J, Xu X, Wu J, Ling Q, et al
    The stratifying value of hangzhou criteria in liver transplantation for hepatocellular carcinoma.
    PLoS One. 2014;9:e93128.
    PubMed     Text format     Abstract available


  561. ULAS A, Turkoz FP, Silay K, Tokluoglu S, et al
    A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer.
    PLoS One. 2014;9:e114471.
    PubMed     Text format     Abstract available


  562. WANNHOFF A, Muller OJ, Friedrich K, Rupp C, et al
    Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosis.
    PLoS One. 2014;9:e112583.
    PubMed     Text format     Abstract available


  563. DVORAK K, Stritesky J, Petrtyl J, Vitek L, et al
    Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice - an exploratory case-control study.
    PLoS One. 2014;9:e111551.
    PubMed     Text format     Abstract available


  564. XIANG Z, Wang S, Xiang Y
    Up-Regulated MicroRNA499a by Hepatitis B Virus Induced Hepatocellular Carcinogenesis via Targeting MAPK6.
    PLoS One. 2014;9:e111410.
    PubMed     Text format     Abstract available


  565. BARDI DA, Halabi MF, Hassandarvish P, Rouhollahi E, et al
    Andrographis paniculata Leaf Extract Prevents Thioacetamide-Induced Liver Cirrhosis in Rats.
    PLoS One. 2014;9:e109424.
    PubMed     Text format     Abstract available


  566. KRAG A, Bendtsen F, Dahl EK, Kjaer A, et al
    Cardiac Function in Patients with Early Cirrhosis during Maximal Beta-Adrenergic Drive: A Dobutamine Stress Study.
    PLoS One. 2014;9:e109179.
    PubMed     Text format     Abstract available


  567. KATO N, Sejima H, Ueda Y, Mori K, et al
    Genetic characterization of hepatitis C virus in long-term RNA replication using li23 cell culture systems.
    PLoS One. 2014;9:e91156.
    PubMed     Text format     Abstract available


  568. QI Z, Li L, Wang X, Gao X, et al
    Bone Marrow Transplantation Concurrently Reconstitutes Donor Liver and Immune System across Host Species Barrier in Mice.
    PLoS One. 2014;9:e106791.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: